UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

☒	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the fiscal year ended December 31, 2023
	For the fiscal year ended December 31, 2024
	or
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from _______ to _____
	For the transition period from _________ to ________

Commission file number: 000-49654

CirTran Corporation

(Exact name of registrant as specified in its charter)

Nevada

68-0121636

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

6360 S Pecos Road, Suite 8, Las Vegas, NV 89120

(Address of principal executive offices, including zip code)

(801) 963-5112

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		None		None

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, Par Value $0.001

(Title of class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No

Indicate by check mark if the registrant is not required to file reports pursuant to the Section 13 or Section 15(d) of the Exchange Act. ☐ Yes ☒ No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or Section 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes ☒ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

	Large accelerated filer ☐		Accelerated filer ☐
	Non-accelerated filer ☒		Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. As of June 30, ~~2023~~2024, the aggregate market value of voting common equity held by nonaffiliates was $~~136~~56,~~527~~500.

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. As of April 1611, ~~2024~~2025, we had 4,945,417 shares of common stock outstanding.

TABLE OF CONTENTS

Item		Page
	Part I
Item 1.	Business	4
Item 1A.	Risk Factors	8
Item 1B.	Unresolved Staff Comments	8
Item 1C.	Cybersecurity	89
Item 2.	Properties	89
Item 3.	Legal Proceedings	9
Item 4.	Mine Safety Disclosures	9
	Part II
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	910
Item 6.	[Reserved]	1011
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1011
Item 7A.	Quantitative and Qualitative Disclosures about Market Risk	1213
Item 8.	Financial Statements and Supplementary Data	F-1
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	1314
Item 9A.	Controls and Procedures	1314
Item 9B.	Other Information	1415
Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	1415
	Part III
Item 10.	Directors, Executive Officers and Corporate Governance	1415
Item 11.	Executive Compensation	1617
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	1719
Item 13.	Certain Relationships and Related Transactions, and Director Independence	1820
Item 14.	Principal Accounting Fees and Services	1920
	Part IV
Item 15.	Exhibit and Financial Statement Schedules	2022
Item 16.	Form 10-K Summary	2223
	Signatures	2324

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This report contains statements about the future, sometimes referred to as “forward-looking” statements. Forward-looking statements are typically identified by use of the words “believe,” “may,” “could,” “should,” “expect,” “anticipate,” “estimate,” “project,” “propose,” “plan,” “intend,” and similar words and expressions. Statements that describe our future strategic goals, plans, objectives, and predictions are also forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements.

Readers of this report are cautioned that any forward-looking statements, including those regarding us or our management’s current beliefs, expectations, anticipations, estimations, projections, strategies, proposals, plans, or intentions, are not guarantees of future performance or results of events and involve risks and uncertainties, such as:

	●	Russia’s recent military invasion of Ukraine has caused significant international political and economic disruption that may adversely affect our operations.

	●	The auditors’ report for our most recent fiscal years contains explanatory paragraphs about our ability to continue as a going concern.

	●	We have new operations that began generating revenues in 2020, after suffering severe operating and legal hurdles in 2016 that forced us to significantly curtail operations.

	●	Our renewed operations have faced the usual risks of beginning a new business, including establishing reliable product sources, new supply and distribution chains, sales, management capabilities, and related requirements, all of which have been exacerbated by a global pandemic.

	●	Our new business will be dependent on maintaining in good standing our manufacturing and distribution agreement with GloBrands and its license agreement with the Flint/Hustler organization to use the HUSTLER® brand name.

	●	We cannot assure that our efforts to identify and commercialize new products for manufacture and distribution will be successful or generate revenue.

	●	Any sizable increase in products being developed, manufactured, and distributed will require skilled management of growth.

	●	All our assets are encumbered to secure the payment of indebtedness convertible to common stock, and if the indebtedness is not converted before April 2027, our default could result in the loss of all our assets.

	●	We will require substantial amounts of additional capital from external sources.

	●	Penny stock regulations impose certain restrictions on resales of our securities, which may cause an investor to lose some or all of its investment.

	●	Risk factors, such as those set forth under “Management’s Discussion and Analysis of Analysis of Financial Condition and Results of Operation” and other factors that are not currently known to us, may emerge from time to time.

The forward-looking statements in this report are based on present circumstances and on our predictions respecting events that have not occurred, that may not occur, or that may occur with different consequences from those we now assume or anticipate. Actual events or results may differ materially from those discussed in the forward-looking statements because of various factors, including the risk factors discussed in this report. These cautionary statements are intended to be applicable to all related forward-looking statements wherever they appear in this report. The forward-looking statements included are made only as of the date of this report.

PART I

ITEM 1. BUSINESS

Introduction

Based on our diversified expertise in manufacturing, marketing, distribution, and technology services in a wide variety of consumer products, including tobacco products, medical devices, and beverages, around the world, we have an innovative and consumer-focused approach to brand portfolio management, resting on a strong understanding of consumers domestically, and we have established a footprint in more than 50 key, international markets.

In early 2020, we completed phase one and two of our development of several HUSTLER®-branded products, which enabled us to generate revenue of about $1.8 million during the year ended December 31, 2023, and about $1.7 million during the year ended December 31, 2022. Our revenue-generating activities capitalized on our 2019 efforts to explore new product opportunities. In late 2019, we entered a five-year manufacturing and distribution agreement with an unrelated party to manufacture, distribute, and sell condoms, electronic tobacco products, cigars, energy drinks, water beverages, and related merchandise, all using the HUSTLER® brand name.

References to “us,” “we,” “our,” and correlative terms refer to CirTran Corporation and our three subsidiaries, LBC Products, Inc., CirTran Products Corp., and CirTran - Asia, Inc., through which we conduct our activities.

Principal Activities

HUSTLER®-branded Products

In 2020, we completed phase one and two of our development of several HUSTLER®-branded products and launched our efforts to manufacture, distribute, and sell condoms, electronic cigarettes, electronic cigars, cigars, hookahs, hookah tobacco, energy drinks, water beverages, and related merchandise, all using the HUSTLER® trademark. We conduct these activities through our wholly owned subsidiary, LBC Products, Inc. (“LBC”), under a December 30, 2019, Exclusive Manufacturing and Distribution Agreement with GloBrands, LLC (“GloBrands). GloBrands is an unaffiliated licensee to market certain products bearing the HUSTLER® trademark.

The Flynt/HUSTLER® organization, a privately held 45-year-old global empire founded by Larry Flynt, operates under the HUSTLER® brand, including Larry Flynt’s HUSTLER® Clubs in 14 locations worldwide, HUSTLER® Hollywood adult retail stores in 60 locations, the luxurious HUSTLER® Casino and Larry Flynt’s Lucky Lady Casino in California, broadcasting outlets serving over 55 countries, and DVD distribution. Larry Flynt’s HUSTLER® Club, located at the south end of The Las Vegas Strip, consists of an approximately 70,000-square-foot gentlemen’s club above a similarly sized retail store that sells erotic clothing, toys, and associated merchandise. Our HUSTLER®-branded products are also distributed in outlets operated by HUSTLER®’s affiliated Deja Vu organization, which operates approximately 200 gentlemen’s clubs and adjacent adult retail stores in major metropolitan cities across the United States and several foreign countries, including the United Kingdom, Australia, France, Canada, and Mexico.

In undertaking this new product manufacturing and distribution opportunity, we have taken advantage of our distribution and manufacturing relationships established in several global locations during the last 20 years.

We continue our efforts to:

●	develop product manufacturing relationships with various foreign and domestic suppliers, including:

	◌	obtaining, sometimes at our cost and for our exclusive benefit, tobacco import regulatory licenses;

	◌	designing product logos and labeling;

	◌	obtaining regulatory approval for our HUSTLER®-brand product labeling where required;

	◌	securing, at our cost and for our exclusive benefit, necessary FDA 510(k) approval for condom manufacturing;

	◌	developing and refining regular and sugar-free energy drink and water assorted flavorings and formulations;

	●	create samples, wholesale and point-of-sale displays, catalogs, and related merchandising materials;

	●	develop digital and hard copy media support, website, product spokesperson content, direct television commercials, print, and miscellaneous media;

	●	establish, through our marketing and distribution relationships, distribution and delivery channels, inventory management, and related logistics;

	●	lease Las Vegas facilities to house our offices, showroom, and warehouse;

	●	assemble a team of contract consultants and support staff to expand into full operations when our business development progresses; and

	●	design data gathering, reporting, and analytical systems to support product and market development and refinement to respond to changing dynamics.

Our GloBrands Manufacturing and Distribution Agreement

Our December 2019 Exclusive Manufacturing and Distribution Agreement with GloBrands grants to us the exclusive right to manufacture, distribute, and sell specified products, including the authority to deal directly with distribution chain participants and to collect all product payments. We are authorized to retain from the collected sales proceeds an amount equal to 120% of our cost of goods sold, plus 10% of gross sales of the covered products. GloBrands reimburses us 105% of certain of our media placement expenses. Our GloBrands’ agreement term extends through November 30, 2024, subject to earlier termination by either party following 60 days’ notice of uncured material default.

Our agreement with GloBrands is subject in all respects to its rights as licensee under its licensing agreements with the Flynt/HUSTLER® organization to use the HUSTLER® brand name. The Flynt/HUSTLER® organization has approved our manufacturing and distribution arrangement. GloBrands is obligated to fully and timely perform and observe all terms, covenants, and conditions of the three underlying licenses between it and the Flynt/Hustler organization, including the payment of required minimum and actual royalties to the Flynt/HUSTLER® organization. Further, GloBrands cannot amend the license agreements or waive or release any material right under the underlying Flynt/HUSTLER® licenses. Under the Exclusive Manufacturing and Distribution Agreement, we transmit royalty payments on GloBrands’ behalf directly to the Flynt/HUSTLER® organization.

We have a limited license to use the HUSTLER® brand name for the exclusive purposes of fulfilling our obligations under the Exclusive Manufacturing and Distribution Agreement.

GloBrands’ License to Use the HUSTLER® Brand Name

Our Exclusive Manufacturing and Distribution Agreement with GloBrands implements its three separate product licenses with the Flynt/HUSTLER organization covering three branded products or product groups (condoms, energy drinks and waters, and natural leaf small cigars and premium cigars, electronic cigarettes/cigars, hookahs, and hookah tobacco), with minimum initial term guaranteed payments. The guaranteed payments are a prepayment of, and are applied to, actual royalties of the gross sales price of products, less freight and returns. The licenses authorize worldwide product distribution through mass retail, drug stores, supermarkets, club stores, direct response, pharmacies casinos/nightclubs, convenience stores, internet sales via licensee’s websites, and miscellaneous other outlets. Each license is automatically renewable for an additional five-year term, subject to adjustment to the amount of the guaranteed payments. All manufacturing, labeling, and marketing materials, samples, and representative products are subject to the prior approval of the Flynt/HUSTLER® organization.

Each license is terminable by the Flynt/HUSTLER® organization if any material default by GloBrands is not cured within 60 days after notice (10 days in the case of nonpayment). We are not entitled to receive a copy of any notice of default.

Business Approach

Our GloBrands-HUSTLER® current activities reflect our commitment and ability to assist our clients in developing their licensed brands and to provide a range of products in various categories for markets globally. We can provide complete product development, manufacturing, and distribution services for a wide range of business sectors. From first concept to design, engineering, prototyping, manufacturing, packaging, marketing, inventory control, distribution, shipping, warranty fulfillment, and customer service.

Consumer Product Commercialization—Contract Marketing

In addition to current activities under our GloBrands-HUSTLER® Manufacturing and Distribution Agreement, we are seeking to commercialize one or more consumer products. We identify what we believe to be the need for a product or other demand and then seek a product that may be distributed to address that demand. When we identify a need, but find no suitable available product, we may design our own product for commercialization.

We pursue contract marketing relationships principally in the domestic consumer products markets, such as home and garden, kitchen, health and beauty, toys, and licensed merchandise for television, sports, and other entertainment properties. If we deem it suitable, we may obtain rights from the product owner to manufacture and market a particular product, generally in consideration of the payment of a royalty, sometimes accompanied with an initial fee. Frequently, owners of undeveloped products or product concepts are seeking branding, marketing, manufacturing, order fulfillment, and distribution assistance.

Our commercialization efforts include developing product packaging, branding the product, arranging third-party manufacturing, establishing distribution channels, and arranging order fulfillment. We anticipate that these activities will generally be undertaken by third parties under contract. In some cases, we may brand a product under a license to use a third-party’s recognized name, as we did in the case of the discontinued Playboy-branded energy drink; seek an endorsement from a publicly recognized celebrity, sports figure, or other person; or obtain the rights to use the image, likeness, or logo of a product or a person, such as a well-known celebrity. Licensed merchandise is then sold and marketed in the entertainment and sports franchise industries. We anticipate that these products will be introduced into the market under either one uniform brand name or separate trademarked names that we originate and own or acquire by license.

The contract-manufacturing industry specializes in providing the program management, technical and administrative support, and manufacturing expertise required to take products from the early design and prototype stages through volume production and distribution of a quality product on time and at a competitive cost. This full range of services gives the customer an opportunity to avoid large capital investments in plant, inventory, equipment, and staffing, so that instead, it can concentrate on innovation, design, and marketing. By using our contract-manufacturing services, customers have the ability to improve the return on their investment with greater flexibility in responding to market demands and exploiting new market opportunities. Our efforts will be led by our current chief executive officer and others that we may hire as employees or engage as independent contractors.

In previous years, we found that customers increasingly required contract manufacturers to provide complete turn-key manufacturing and material handling services, rather than working on a consignment basis in which the customer supplies all materials, and the contract manufacturer supplies only labor. Turn-key contracts involve design, manufacturing and engineering support, procurement of all materials, and sophisticated in-circuit and functional testing and distribution. The manufacturing partnership between customers and contract manufacturers involves an increased use of “just-in-time” inventory management techniques that minimize the customer’s investment in component inventories, personnel, and related facilities, thereby reducing its costs.

Based on the trends we have observed in the contract-manufacturing industry, we believe we will benefit from the increased market acceptance of, and reliance upon, the use of manufacturing specialists by many original equipment manufacturers, or OEMs, marketing firms, distributors, and national retailers. We believe the trend towards outsourcing manufacturing will continue. OEMs use manufacturing specialists for many reasons, including reducing the time it takes to bring new products to market, reducing the initial investment required, accessing leading manufacturing technology, gaining the ability to better focus resources in other value-added areas, and improving inventory management and purchasing power. An important element of our strategy is to establish partnerships with major and emerging OEM leaders in diverse segments across our target industries. Due to the costs inherent in supporting customer relationships, we focus on customers with which the opportunity exists to develop long-term business relationships. Our goal is to provide our customers with total manufacturing solutions through third-party providers for both new and more mature products, as well as across product generations—an idea we call “Concept to Consumer.”

We have also previously designed, engineered, manufactured, and supplied international electronic consumer products and general merchandise for various marketers, distributors, and retailers selling overseas. We have provided manufacturing services to the direct-response and retail consumer markets. Our experience and expertise enable us to enter a project at various phases: engineering and design; product development and prototyping; tooling; and high-volume manufacturing. Our contacts with Asian suppliers have helped us to maintain our status as an international contract manufacturer for multiple products in a wide variety of industries, which will allow us to target larger-scale contracts.

We have developed markets for several product lines, including medical devices, beverages, tobacco products, fitness and exercise products, household and kitchen products and appliances, and health and beauty aids, some of which are manufactured in China. We anticipate that offshore contract manufacturing will play an increased role moving forward as resources become available to us.

All marketing costs are reimbursed by the entity the Company licenses its products from. Any expense attributed to the Company in negligible.

Sales and Marketing

We review opportunities to identify products that we may market through current sales channels. We also seek new paths to deliver products and services directly to end users and are pursuing strategic and reciprocal relationships with retail distribution firms whereby they would act as our retail distribution arm and we would act as their manufacturing arm, with each party giving the other priority and first opportunity to work on the other’s products.

We believe there may be a significant marketing advantage related to our development and introduction of the suite of products under the HUSTLER® brand that identifies our products and outweighs related costs.

Our contacts in Central America, Thailand, Vietnam, China, and other Asian countries may allow us to increase our manufacturing capacity and output with minimal capital investment required. By using various subcontractors, we may leverage our upfront payments for inventories and tooling to control costs and receive benefits from economies of scale in Asian manufacturing facilities.

Typically, we may be required to prepay a portion of the purchase order price for materials. In exchange for financial commitments, we may receive dedicated manufacturing responsiveness and eliminate the costly expense associated with capitalizing completely proprietary facilities. For example, we previously expanded our manufacturing capabilities for our beverage division outside the United States to accommodate international customers by contracting with manufacturers in Hungary, The Netherlands, South Africa, and India. This is also the case moving forward with the current branded products manufactured and distributed for GloBrands.

During a typical contract manufacturing sales process, a customer provides us with specifications for the product it wants, and we develop a bid price for manufacturing a minimum quantity that includes manufacture engineering, parts, labor, testing, and shipping. If the bid is accepted, the customer is required to purchase an agreed minimum quantity, and additional product is sold through purchase orders issued under the original contract. Special engineering services are provided at either an hourly rate or a fixed contract price for a specified task.

Competition

As we seek to develop and introduce new private label or similarly branded proprietary products, we may be dependent on our ability to acquire licensing rights with established, broadly recognized brand names, which are typically owned by large, international firms that carefully guard their name’s integrity and reputation. We have little market position or operating history to support our efforts to develop exclusive marketing relationships. On the contrary, we may be adversely affected by the history of our relationship with Playboy Enterprises, Inc., in distributing its private label Playboy nonalcoholic energy drink.

Competition in our targeted markets is based on manufacturing technology, merchandise quality, responsiveness, the provision of value-added services, and price. To be competitive, we must provide technologically advanced manufacturing services, maintain quality levels, offer flexible delivery schedules, and deliver finished products on a reliable basis and for a favorable price.

The manufacturing services industry is large and diverse and serviced by many companies, including several that have achieved significant market share. We will compete with different companies depending on the type of service or geographic area. Certain of our competitors may have greater manufacturing, financial, research and development, and marketing resources than we have.

We will also face competition from current and prospective customers that evaluate our capabilities against the merits of manufacturing products internally.

Regulation

We or the products we sell are subject to typical federal, state, and local regulations and laws governing the operations of manufacturing facilities, including environmental disposal, storage, and discharge regulations and laws; employee safety laws and regulations; and labor practices laws and regulations. We and the firms that manufacture the products that we market and distribute typically require compliance with applicable good manufacturing procedures, including FDA 510(k) certification for medical devices such as condoms. We coordinate those efforts and, when we bear the related costs, hold the exclusive rights under those regulatory clearances. We are primarily responsible for complying with importing and interstate shipping licenses, registrations, reporting, and related excise tax payments for tobacco products we handle.

We generally are not required under current laws and regulations to obtain or maintain any specialized or agency-specific other licenses, permits, or authorizations to conduct our manufacturing services, but we must obtain licenses to sell tobacco products in all states. We believe we are in substantial compliance with all relevant regulations applicable to our business and operations. All international sales permits are the responsibility of the local distributors, which are required to obtain all local licenses and permits.

Employees

As of December 31, ~~2023~~2024, we had four full-time employees, including our officers and directors, and ~~tweny~~twenty-three part-time contract workers. We now rely on part-time and contract workers, independent contractors, and consultants to meet our needs while minimizing fixed overhead. We expect to continue to rely on this strategy in the future as our increasing activities required more personnel.

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 1C. CYBERSECURITY

Cybersecurity Risk Management and Strategy

We have developed and maintain a cybersecurity risk management methodology intended to protect the confidentiality, integrity, and availability of our critical systems and information. Our cybersecurity risk management methodology is integrated into our overall enterprise risk management, and shares common methodologies, reporting channels and governance processes that apply across the Company to other legal, compliance, strategic, operational, and financial risk areas. As part of our overall risk management processes and procedures, we have instituted a cybersecurity awareness designed to identify, assess and manage material risks from cybersecurity threats, including by engaging a third-party cybersecurity service provider, which communicates directly with our management and compliance personnel. The cyber risk management methodology involves risk assessments, implementation of security measures and ongoing monitoring of systems and networks, including networks on which we rely. Through our cybersecurity awareness, the current threat landscape is actively monitored in an effort to identify material risks arising from new and evolving cybersecurity threats. We may engage external experts, including cybersecurity assessors, consultants and auditors to evaluate cybersecurity measures and risk management processes as needed. We also depend on and engage various third parties, including suppliers, vendors and service providers in connection with our operations. Our risk management, legal, and compliance personnel oversee and identify, including through a third-party cybersecurity service provider, material risks from cybersecurity threats associated with our use of such entities.

Our cybersecurity risk management methodology includes:

We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, that have materially affected us, including our operations, business strategy, results of operations, or financial condition. We face risks from cybersecurity threats that, if realized, are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition.

Cybersecurity Governance

Our Board of Directors oversees our risk management, including our information technology and cybersecurity policies, procedures, and risk assessments. Management reports to our Board of Directors on information security matters as necessary, regarding any significant cybersecurity incidents, as well as any incidents with lesser impact potential.

One of the key functions of our Board of Directors is informed oversight of our various processes for managing risk. An overall review of risk is inherent in our Board of Directors ongoing consideration of our long-term strategies, transactions and other matters presented to and discussed by the Board of Directors. This includes a discussion of the likelihood and potential magnitude of various risk.

ITEM 2. PROPERTIES

We sublease a 2,500-square-foot office, showroom, and warehouse in Las Vegas, NV, for $2,500 per month ~~from GloBrands under a lease that expired in October 2022. In November 2022~~, ~~the lease was continued~~ on a month- to- month basis, from GloBrands. We believe that the facilities described above are generally in good condition, well maintained, and suitable and adequate for our current needs.

ITEM 3. LEGAL PROCEEDINGS

From time to time, we may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. All judgments, including interest, have been booked as liabilities, except where we believe collection or enforcement of the judgments is barred by the applicable statute of limitations, in which case the liabilities have been eliminated. We consider litigation reduced to judgment as no longer pending. However, in certain circumstances, a litigant can initiate further proceedings following the entry of a non-appealable final judgment and the passage of the applicable statute of limitations on the enforcement of a judgment to seek enforcement or further relief. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. As of December 31, ~~2023~~2024, we were not a party to any material pending litigation, and no lawsuits have been threatened by or against us.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is quoted on the Pink tier of the OTC Markets Group under the trading symbol “CIRX.” These over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down, or commission, and may not necessarily represent actual transactions. Since our inception, the sporadic trading activity in our common stock and the price fluctuations have been volatile, and we cannot assure that any market for our common stock will be maintained.

The following table sets forth the range of low and high closing sale prices for our common stock for each of the periods indicated, as reported and summarized by the Pink tier of the OTC Markets Group:

	Low		High
2024:
Fourth Quarter	$	0.006	$	0.03
Third Quarter	$	0.0006	$	0.0124
Second Quarter	$	0.012	$	0.023
First Quarter	$	0.015	$	0.025
2023:
Fourth Quarter	$	0.022	$	0.026
Third Quarter	$	0.016	$	0.029
Second Quarter	$	0.015	$	0.029
First Quarter	$	0.021	$	0.031
2022:
Fourth Quarter	$	0.021	$	0.045
Third Quarter	$	0.031	$	0.06
Second Quarter	$	0.05	$	0.065
First Quarter	$	0.043	$	0.09

On ~~March~~April 2610, ~~2024~~2025, the closing price per share for the most recent sale of our common stock on the Pink tier of the OTC Markets Group was $0.~~025~~034. We have 498 stockholders of record of our common stock. As of ~~March~~April 2610, 2024, we had 4,945,417 shares of our common stock issued and outstanding.

Our shares of common stock are subject to the “penny stock” and other rules of the Exchange Act. In general terms, “penny stock” is defined as any equity security that has a market price less than $5.00 per share that is not traded on a national securities exchange or that has an exercise price of less than $5.00 per share, subject to certain exceptions. As a result, our common stock is subject to rules that impose additional sales practice requirements on broker-dealers that sell these securities to persons other than established customers and accredited investors (generally those with assets more than $1,000,000 or annual income exceeding $200,000, or $300,000 together with their spouse).

Transactions covered by these rules are subject to additional sales practice requirements, including the broker-dealer must make a special suitability determination for the purchase of these securities and have received the purchaser’s written consent to the transaction before the purchase. These rules may restrict the ability of broker-dealers to trade or maintain a market in our common stock, to the extent it is penny stock, and may affect the ability of stockholders to sell their shares.

Dividends

Holders of shares of common stock are entitled to receive dividends for our common stock when, as, and if declared by the board of directors out of funds legally available ~~therefor~~. We have not paid any dividends on our common stock and intend to retain earnings, if any, to finance the development and expansion of our business. Future dividend policy is subject to the discretion of the board of directors and will depend upon the number of factors, including future revenues, capital requirements, overall financial condition, and such other factors as our board of directors deems relevant.

Equity Compensation Plan

The following table provides information as of December 31, ~~2023~~2024, respecting our compensation plans (including individual compensation arrangements) under which our equity securities are authorized for issuance.

Plan Category	Number of Securities To Be Issued upon Exercise of Outstanding Options, Warrants and Rights (a)		Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights (b)		Number of Securities Remaining Available for Future Issuance under Equity Compensation Plans (excluding securities reflected in column (a)(c)
Equity compensation plans approved by security holders		4032,000	$	0.03		344,000
Equity compensation plans not approved by security holders		—–		—–		—–
Total		4032,000	$	0.03		344,000

Recent Sales of Unregistered Securities

None.

ITEM 6. [RESERVED]

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

Except for the historical information, the following discussion contains forward-looking statements that are subject to risks and uncertainties. We caution you not to put undue reliance on any forward-looking statements, which speak only as of the date of this report. Our actual results or actions may differ materially from these forward-looking statements for many reasons, including the risks described in “Risk Factors” and elsewhere in this annual report. Our discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and related notes and with the understanding that our actual future results may be materially different from what we currently expect.

Introduction

During the year ended December 31, ~~2023~~2024, our business activities generated revenue of $1,~~616~~296,~~148~~796. In 2020, we completed phase one and two of our development of all HUSTLER®-branded products, related to our 2019 five-year manufacturing and distribution agreement with an unrelated party to manufacture, distribute, and sell condoms, electronic tobacco products, cigars, energy drinks, water beverages, and related merchandise, all using the HUSTLER® brand name.

Going Concern

We have suffered substantial losses. The future of our company is dependent upon our ability to continue to generate revenues sufficient to offset operating costs or recover start-up costs under our GloBrands-HUSTLER® Exclusive Manufacturing and Distribution Agreement signed in December 2019. Management intends to seek additional capital through a private placement or public offering of its common stock, if necessary. Our auditors have expressed a going concern in their opinion, which raises substantial doubts about our ability to continue as a going concern.

Results of Operations

Comparison of Years Ended December 31, ~~2023~~2024 and ~~2022~~2023

Sales and Cost of Sales

We had revenues of $1,~~616~~296,~~148~~796 and $1,~~719~~616,~~358~~148 during the years ended December 31, ~~2023~~2024 and ~~2022~~2023, respectively, a decrease of $~~103~~319,~~210~~352 or 6 19.8%. We had cost of sales of $~~609~~458,~~651~~158 and $~~696~~609,~~548~~651, respectively, for gross profit of $1838,~~006,497~~638 and $1,~~022~~006,~~810~~497, respectively. Revenues are derived from the design, manufacture, and delivery of certain licensed products in accordance with our GloBrands-HUSTLER® distribution agreement. ~~The~~We ~~increase~~had inhigher revenue in the ~~current~~ prior period is due to aadditional ~~decrease~~income infrom the ~~sale~~licensing of ~~Vape~~novelties ~~products~~ in ~~California~~an ~~due~~international ~~to their ban on flavored tobacco~~territory.

Operating Expenses

During the year ended December 31, ~~2023,~~2024 ~~selling, general,~~ and ~~administrative~~2023, ~~expenses and~~ employee costs were ~~approximately~~ $1515,~~021,000,~~807 asand ~~compared to approximately~~ $1511,~~545,000~~519 ~~for the same period in 2022~~respectively, aan ~~decrease~~increase of ~~$524,000~~only ~~or 34%. Selling, general, and administrative expenses were~~ $~~509~~4,~~895~~288 ~~and $1,004,003, respectively, a decrease of $494,108~~ or 490.28%. ~~The decrease in operating expenses period over period is the result of focusing on products with less marketing spending demands and spending less on marketing consultants.~~

During the year ended December 31, 2024 and 2023, selling, general, and administrative expenses were $873,570 and $509,895, respectively, an increase of $363,675 or 71.3%. The increase in operating expenses year over year is the result of additional marketing expense to launch product on detail chains.

Other Income and Expense

For the year ended December 31, ~~2023~~2024, we had total other expense of $~~536~~1,~~782~~996,615. This consisted of ~~interest~~$790,589 ~~expense~~ of ~~$768~~interest expense,~~899,~~ aan impairment loss on ~~the~~out ~~fair~~investment ~~value~~ of ~~derivative~~$52,000 ~~liabilities~~and a loss of $~~292~~1,~~100 a~~161,498 ~~gain~~ on ~~settlement~~derivative ofvaluation. ~~debt~~We also had other income of $~~194,709,~~250 and a gain on ~~forgiveness~~the ofdisposal ~~debt~~ of ~~$328,384~~property ~~and other income~~ of $17,~~124~~222.

~~Other~~For ~~income and expenses during~~ the year ended December 31, ~~2022~~2023, we had total other expense of $536,782. This consisted of interest expense of $~~709~~768,~~414~~899, ~~and~~ a loss on the fair value of derivative liabilities of ~~approximately~~$292,100, a gain on settlement of debt of $66194,~~040~~709, a gain on forgiveness of debt of $328,384 and other income of $1,124.

As a result of the foregoing, we had a net loss from continuing operations of $~~551~~2,~~699~~547,354 as compared to $1551,~~297,737~~699 in the prior year.

11For the year ended December 31, 2024, we recognized a loss from discontinued operations of $153,886 due to interest expense.

For the year ended December 31, 2023, we recognized a gain from discontinued operations of $20,831,526 due to the extinguishment of time barred debt.

For the year ended December 31, 2022, we recognized a loss from discontinued operations of $153,466.

Liquidity and Capital Resources

We have had a history of losses from operations, as our expenses have been greater than our revenue. Our accumulated deficit is approximately $5961.6 million at December 31, ~~2023~~2024.

Operating Activities

During the year ended December 31, ~~2023~~2024, operations used $7246,~~607~~354 of net cash, comprised of a loss from ~~continuing~~discontinued operations of $~~551~~153,~~699~~886, noncash items totaling $201,~~948~~310,~~388~~404 consisting primarily of losses recognized from the changes in fair values of derivative liabilities, ~~debt discount amortization~~ and a gain of $20,831,526 from discontinued operations. Changes in working capital totaled $587,421. During the year ended December 31, 2022, operations generated $159,304 of net cash, comprised of a loss from continuing operations of $1,502,091, noncash items totaling $337,367 consisting primarily of losses recognized from the changes in fair values of derivative liabilities, debt discount amortization ~~and discontinued operations~~. Changes in working capital totaled $1,~~273~~122,~~140.~~020

During the year ended December 31, 2023, weoperations ~~were~~used ~~provided approximately~~ $6372,~~000~~607 of net cash, ~~in financing activities mainly~~ comprised of ~~repayments~~a ~~on related-party~~loss ~~loans that totaled $47,478 and proceeds~~ from ~~related-party~~continuing ~~loans~~operations of $~~114~~551,~~600. During the year ended December 31~~699, ~~2022,~~noncash weitems ~~used~~totaling ~~approximately~~ $~~147~~20,~~000~~948,388 consisting primarily of ~~net~~losses ~~cash~~recognized from ~~financing~~the ~~activities~~changes ~~mainly~~in ~~comprised~~fair values of ~~repayments~~derivative onliabilities, ~~related-party loans~~debt ~~that~~discount ~~totaled~~amortization and a gain of $~~155~~20,~~000~~831,526 ~~and~~from ~~proceeds~~discontinued ~~from~~operations. ~~related-party~~Changes ~~loans~~in ofworking capital totaled $8587,~~000~~421.

During the year ended December 31, 2024, we were provided with $15,400 of net cash from the sale of an automobile.

During the year ended December 31, 2024, we were provided $30,954 of net cash in financing activities mainly comprised of repayments on related-party loans that totaled $61,336 and proceeds from related-party loans of $61,906.

During the year ended December 31, 2023, we were provided approximately $63,000 of net cash in financing activities mainly comprised of repayments on related-party loans that totaled $47,478 and proceeds from related-party loans of $114,600.

Our Capital Resources and Anticipated Requirements

Our monthly operating costs are approximately $35,000 per month, excluding approximately $50,000 of accruing interest expense and capital expenditures. We continue to focus on generating revenue and reducing our monthly business expenses through cost reductions and operational streamlining. We have only recently begun to generate enough cash to sustain our day-to-day operations, and we expect to access external capital resources in the future to fund any new projects we may undertake. We cannot assure that we will be successful in obtaining such capital.

If we seek infusions of capital from investors, it is unlikely that we will be able to obtain additional debt financing. If we did incur additional debt, we would be required to devote additional cash flow to servicing the debt and securing the debt with assets.

Our issuance of additional shares for equity or for conversion of debt could dilute the value of our common stock and existing stockholders’ positions.

Convertible Debentures and Notes Payable

We currently have an outstanding amended, restated, and consolidated secured convertible debenture with Tekfine, LLC, an unrelated entity, with a maturity date of April 30, 2027, to the extent not previously converted. The amended debenture has a total outstanding principal balance of $2.4 million, with accrued interest of $~~1.7~~2 million as of December 31, ~~2022~~2024. We also have four additional convertible debentures with Tekfine with maturity dates ranging from February 28, 2022, until May 30, 2022, totaling $275,000, unless earlier converted. The convertible debentures and accrued interest are convertible into shares of our common stock at the lower of $100 or $0.10 (depending on the instrument) or the lowest bid price for the 20 trading days prior to conversion.

We have received advances from related parties totaling $~~114~~61,~~600~~906 and $8114,~~137~~600 during the years ended December 31, ~~2023~~2024 and ~~2022~~2023, respectively, as well as making repayments on related-party loans of $4761,~~478~~336 and $~~154~~47,~~832~~478 during the years ended December 31, ~~2023~~2024 and ~~2022~~2023, respectively.

Critical Accounting Policies

~~Refer~~The Company considers its accounting for the fair value of financial instruments, revenue recognition, accounts receivable, allowance for doubtful accounts and inventory among its critical accounting policies. The Company maintains an allowance for doubtful accounts to reflect management’s estimate of the amount of receivables that will not be collected. This estimate is considered a critical accounting estimate due to the subjectivity involved in evaluating the collectability of accounts receivable. The fair value measurement of derivative instruments is also one of our critical accounting estimates due to the complexity and subjectivity involved. These estimates often require the use of valuation models that rely on unobservable inputs. Refer to Note 2 of our financial statements contained elsewhere in this Form 10-K for a more detail description of each, and a summary of all our critical accounting policies and recently ~~adopting~~ adopted and issued accounting standards.

ITEM 7a. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

1213

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

	Page
Report of Independent Registered Public Accounting Firm (PCAOB ID No. 05525)	F-2
Consolidated Balance Sheets as of December 31, 2023 and 2022	F-3
Consolidated Balance Sheets as of December 31, 2024 and 2023	F-3
Consolidated Statements of Operations for the Years Ended December 31, 2023 and 2022	F-4
Consolidated Statements of Operations for the Years Ended December 31, 2024 and 2023	F-4
Consolidated Statements of Stockholders’ Deficit for the Years Ended December 31, 2023 and 2022	F-5
Consolidated Statements of Stockholders’ Deficit for the Years Ended December 31, 2024 and 2023	F-5
Consolidated Statements of Cash Flows for the Years Ended December 31, 2023 and 2022	F-6
Consolidated Statements of Cash Flows for the Years Ended December 31, 2024 and 2023	F-6
Notes to the Consolidated Financial Statements	F-7

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of CirTran Corporation

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of CirTran Corporation (“the Company”) as of December 31, ~~2023~~2024 and ~~2022~~2023, and the related consolidated statements of operations, stockholders’ deficit, and cash flows for each of the years in the two-year period ended December 31, ~~2023~~2024, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, ~~2023~~2024 and ~~2022~~2023 and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, ~~2023~~2024, in conformity with accounting principles generally accepted in the United States of America.

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company has ana ~~accumulated~~working ~~deficit~~capital deficiency, a net ~~losses,~~loss ~~and~~from ~~negative~~continuing ~~cash~~operations, ~~flows~~and ~~from~~an ~~operations~~accumulated deficit. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical audit matters.

Fruci & Associates II, PLLC – PCAOB ID #05525

We have served as the Company’s auditor since 2020.

Spokane, Washington

April 19 15, ~~2024~~2025

F-2

CIRTRAN CORPORATION

CONSOLIDATED BALANCE SHEETS

	December 31, 2023			December 31, 2022
	December 31, 2024			December 31, 2023
ASSETS
Current assets:
Cash	$	—		$	~~18,081~~—
Inventory		~~815~~737,~~612~~223			~~816~~815,~~014~~612
Deposits on inventory		2628,~~983~~803			4026,~~440~~983
Deposits on inventory - related party		~~224,411~~637			~~417~~224,~~633~~411
Deposits on inventory		637			224,411
Accounts receivable, net of allowance for doubtful accounts of $0 and $39,438, respectively		21,536			62,873
Accounts receivable, net		25,641			21,536
Other current assets		~~441~~485,~~095~~621			~~328~~441,~~468~~095
Total current assets		1,~~529~~277,~~637~~925			1,~~683~~529,~~509~~637
Investment in securities at cost		~~300~~248,000			300,000
Right-of-use asset		—			—
Property and equipment, net of accumulated depreciation		6,407			18,925
Property and equipment, net of accumulated depreciation		18,925			15,018
Total assets	$	1,532,332		$	1,848,562
Total assets	$	1,848,562		$	1,998,527
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	~~625~~762,~~848~~440		$	2625,~~323,917~~848
Liabilities for product returns and credits		8,701			—
Cash overdraft		30,384			—
Related-party payable		—			13,740
Liabilities for product returns and credits		70,054			8,701
Accounts payable Related party
Short-term advances payable		162,966			172,966
Short-term advances payable		172,966			58,366
Short-term advances payable - related parties		22,452			21,882
Short-term advances payable - related parties		21,882			21,882
Short-term advances payable		22,452			21,882
Short-term advances payable
Accrued liabilities		2,776,008			2,889,389
Accrued liabilities		2,889,389			2,079,252
Accrued payroll and compensation expense		5,381,549			5,067,213
Accrued payroll and compensation expense		5,067,213			4,794,836
Accrued interest, current portion		6,281,805			5,758,603
Accrued interest, current portion		5,758,603			5,214,530
Convertible debenture, current portion, net of discounts		264,284			264,284
Note payable, current portion		90,000			90,000
Note payable to stockholders		151,833			~~182~~151,~~129~~833
Note payable		151,833			151,833
Derivative liability		12,~~296~~458,~~937~~435			1,~~004~~296,~~837~~937
Liabilities from discontinued operations		4,~~511~~664,~~075~~960			254,~~342~~511,~~601~~075
Total current liabilities:		2023,~~858~~117,~~731~~170			4120,~~390~~858,~~374~~731
Deferred tax liability		~~55,946~~—			5055,~~888~~946
Note payable, net of current portion		~~634~~643,~~636~~000			~~656~~634,~~000~~636
Convertible debenture, net of current portion, net of discount		2,~~077~~177,~~934~~723			12,~~968~~077,~~310~~934
Total liabilities		2325,~~627~~937,~~247~~893			4423,~~065~~627,~~572~~247
Commitments and contingencies		—			—
Stockholders’ deficit:
Common stock, par value $0.001; 100,000,000 shares authorized; 4,945,417 shares issued and outstanding		4,945			4,945
Additional paid-in capital		37,233,561			37,233,561
Accumulated deficit		(5961,~~017~~644,~~191~~067	)		(7959,~~305~~017,~~551~~191	)
Total stockholders’ deficit		(2124,~~778~~405,~~685~~561	)		(4221,~~067~~778,~~045~~685	)
Total liabilities and stockholders’ deficit	$	1,~~848~~532,~~562~~332		$	1,~~998~~848,~~527~~562

The accompanying notes are an integral part of these consolidated financial statements.

F-3

CIRTRAN CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

	2023			2022
	2024			2023
	For the Years Ended December 31,
	2023			2022
	2024			2023
Net sales	$	1,~~616~~296,~~148~~796		$	1,~~719~~616,~~358~~148
Cost of sales		~~609~~458,~~651~~158			~~696~~609,~~548~~651
Gross profit		1838,~~006,497~~638			1,~~022~~006,~~810~~497
Operating expenses
Employee costs		~~511~~515,~~519~~807			~~541~~511,~~090~~519
Selling, general and administrative expenses		~~509~~873,~~895~~570			1509,~~004,003~~895
Total operating expenses		1,~~021~~389,~~414~~377			1,~~545~~021,~~093~~414
Income (loss) from operations		(14,917	)		(522,283	)
Loss from operations		(550,739	)		(14,917	)
Other income (expense)
Interest expense		(~~768~~790,~~899~~589	)		(~~709~~768,~~414~~899	)
Gain on settlement of debt		~~194,709~~—			—194,709
Gain on forgiveness of debt		~~328,384~~—			—328,384
Loss on derivative valuation		(292,100	)		(66,040	)
Gain on disposal of equipment		7,222			—
Other income		1,124			—
Impairment of investment		(52,000	)
Total other expense		(536,782	)		(775,454	)
Loss on derivative valuation		(1,161,498	)		(292,100	)
Net loss from continuing operations		(551,699	)		(1,297,737	)
Other income		250			1,124
Gain (loss) from discontinued operations		20,831,526			(153,466	)
Total other expense		(1,996,615	)		(536,782	)
Net (loss) income before income tax		20,279,827			(1,451,203	)
Net loss from continuing operations		(2,547,354	)		(551,699	)
Income tax benefit (expense)		8,533			(50,888	)
(Loss) income from discontinued operations		(153,886	)		20,831,526
Net (loss) income	$	20,288,360		$	(1,502,091	)
Net (loss) income before income tax		(2,701,240	)		20,279,827
Net loss from continuing operations per common share, basic and diluted	$	(0.11	)	$	(0.27	)
Income tax		74,364			8,533
Net loss from discontinued operations per common share, basic and diluted	$	4.21		$	(0.03	)
Net (loss) income	$	(2,626,876	)	$	20,288,360
Net loss per common share, basic and diluted	$	4.10		$	(0.30	)
Net loss from continuing operations per common share, basic and diluted	$	(0.50	)	$	(0.11	)
Net (loss) income from discontinued operations per common share, basic and diluted	$	(0.03	)	$	4.21
Net (loss) income per common share, basic and diluted	$	(0.53	)	$	4.10
Basic and diluted weighted average common shares outstanding		4,945,417			4,945,417

The accompanying notes are an integral part of these consolidated financial statements.

F-4

CIRTRAN CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED DECEMBER 31, ~~2023~~2024 AND ~~2022~~2023

	Shares		Amount		Capital		Deficit			deficit
	Common Stock				Additional Paid-in		Accumulated			Total stockholders’
	Shares		Amount		Capital		Deficit			deficit
Balance, December 31, 2021		4,945,417	$	4,945	$	37,233,561	$	(77,803,460	)	$	(40,564,954	)
Balance, December 31, 2022		4,945,417	$	4,945	$	37,233,561	$	(79,305,551	)	$	(42,067,045	)
Net loss		—		—		—		(1,502,091	)		(1,502,091	)
Balance, December 31, 2022		4,945,417		4,945		37,233,561		(79,305,551	)		(42,067,045	)
Balance		4,945,417		4,945		37,233,561		(79,305,551	)		(42,067,045	)
Net income		—		—		—		20,288,360			20,288,360
Net income (loss)		—		—		—		20,288,360			20,288,360
Balance, December 31, 2023		4,945,417		4,945		37,233,561		(59,017,191	)		(21,778,685	)
Balance, December 31, 2023		4,945,417	$	4,945	$	37,233,561	$	(59,017,191	)	$	(21,778,685	)
Balance		4,945,417		4,945		37,233,561		(59,017,191	)		(21,778,685	)
Balance		4,945,417	$	4,945	$	37,233,561	$	(59,017,191	)	$	(21,778,685	)
Net loss		—		—		—		(2,626,876	)		(2,626,876	)
Net income (loss)		—		—		—		(2,626,876	)		(2,626,876	)
Balance, December 31, 2024		4,945,417	$	4,945	$	37,233,561	$	(61,644,067	)	$	(24,405,561	)
Balance		4,945,417	$	4,945	$	37,233,561	$	(61,644,067	)	$	(24,405,561	)

The accompanying notes are an integral part of these consolidated financial statements.

F-5

CIRTRAN CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

	2023			2022
	2024			2023
	For the Years Ended December 31,
	2023			2022
	2024			2023
Cash flows from operating activities
Net income (loss)	$	20,288,360		$	(1,502,091	)
Net ( loss) income	$	(2,626,876	)	$	20,288,360
Adjustments to reconcile net income to net cash (used) provided by operating activities:
Adjustments to reconcile net (loss) income to net cash used by operating activities:
(Gain) loss from discontinued operations		(20,831,526	)		153,466
Loss (gain) from discontinued operations		153,886			(20,831,526	)
Depreciation expense		4,~~507~~340			34,~~881~~507
Loss on derivative valuation		~~292~~1,~~100~~161,498			66292,~~040~~100
Debt discount amortization		~~109~~99,~~624~~788			91109,~~689~~624
Gain on settlement of debt		(194,709	)		—
Gain on disposal of equipment		(7,222	)		—
Gain on forgiveness of debt		(328,384	)		—
Loss on impairment of investment		52,000			—
Amortization of right-of-use asset to rent expense		—			22,291
Gain on settlement of debt		—			(194,709	)
Gain on forgiveness of debt		—			(328,384	)
Changes in operating assets and liabilities:
Inventory		~~402~~78,389			~~(278,053~~402	)
Deposits on inventory		13(1,~~457~~820	)		~~(28~~13,~~801~~457	)
Deposits on inventory - related party		~~193~~223,~~222~~774			~~(330~~193,~~591~~222	)
Accounts receivable		41(4,~~337~~105	)		~~149~~41,~~371~~337
Other current assets		(~~112~~44,~~627~~526	)		(60112,~~648~~627	)
Accounts payable		(1134,~~188,715~~958	)		~~399~~(1,~~949~~188,715	)
Liabilities for product returns and credits		861,~~701~~353			—8,701
Accrued liabilities		~~810~~(113,~~136~~383	)		~~644~~810,~~758~~136
Payments for lease liability		—			(22,291	)
Income tax liability		(55,946	)		5,058
Accrued payroll and compensation		~~272~~314,~~377~~336			~~465~~272,~~133~~377
Accrued interest		~~544~~523,~~073~~202			~~334~~544,~~313~~073
Accrued tax liability		5,058			50,888
Net cash used by operating activities		(46,354	)		(72,607	)
Net cash (used) provided by operating activities		(72,607	)		159,304
Cash flows from investing activities:
Purchase of property and equipment		~~(8,414~~—	)		—(8,414	)
Net Cash used in investing activities		(8,414	)		—
Proceeds from sale of automobile		15,400			—
Net Cash used in investing activities		15,400			(8,414	)
Cash flows from financing activities:
Repayments of loans payable		(4,182	)		—
Bank overdraft		30,384			—
Proceeds from related-party loans		114,600			8,137
Repayments of loans payable		—			(4,182	)
Repayments of related-party loans		(47,478	)		(154,832	)
Proceeds from related-party loans		61,906			114,600
Net Cash provided by (used in) financing activities		62,940			(146,695	)
Repayments of related-party loans		(61,336	)		(47,478	)
Net change in cash		(18,081	)		12,609
Net Cash provided by financing activities		30,954			62,940
Cash, beginning of year		18,081			5,472
Net change in cash		—			(18,081	)
Cash, end of year	$	—		$	18,081
Cash, beginning of year		—			18,081
Cash, end of year	$	—		$	—
Supplemental disclosure of cash flow information:
Cash paid for interest	$	—		$	—
Cash paid for income taxes	$	—		$	—

The accompanying notes are an integral part of these consolidated financial statements.

F-6

CIRTRAN CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, ~~2023~~2024

NOTE 1 — ORGANIZATION AND NATURE OF OPERATIONS

In 1987, CirTran Corporation was incorporated in Nevada under the name Vermillion Ventures, Inc., for the purpose of acquiring other operating corporate entities. We were largely inactive until July 1, 2000, when our wholly owned subsidiary, CirTran Corporation (Utah), acquired substantially all the assets and certain liabilities of Circuit Technology, Inc., founded by our president, Iehab Hawatmeh.

We, together with our majority-owned subsidiaries, manufacture, distribute, and sell condoms, electronic tobacco products, cigars, energy drinks, water beverages, and related merchandise, all using the HUSTLER® brand name. Since entering our 2019 five-year manufacturing and distribution agreement with an unrelated party, our efforts have been devoted to phase one of our development of all HUSTLER®-branded products, which led us to generating revenue during 2020 for the first time in several years. Business continued to thrive in the States and some international countries, expanding across borders and reaching new markets. Despite challenges, The Company adapted and flourished, driven by great brand and product categories. This growth was not only boosted by the domestic economy but also established a global presence, solidifying the foundation for future success.

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.

Principles of Consolidation

The consolidated financial statements include the accounts of the company and our wholly owned subsidiaries: CirTran Products Corp., LBC Products, Inc., and CirTran Asia, Inc. Intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

In preparing the financial statements in accordance with US GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from those estimates.

Concentrations of Credit Risk

We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may exceed the Federal Deposit Insurance Corporation insurable limit.

Cash Equivalents

We consider all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of December 31, ~~2023~~2024 and ~~2022~~2023.

F-7

Revenue Recognition

We follow Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, for revenue recognition. Adoption of ASC 606 did not have a significant impact on our financial statements. We generate revenue by providing product design services and through the sales of tangible product. We recognize revenue upon transfer of control of promised products or services to customers in an amount that reflects the consideration expected to be received in exchange for those products or services. We determine the transaction price associated with each deliverable based on the unique contract with the customer, which is a stand-alone contract that we retain the right to accept or reject. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

During the years ended December 31, ~~2023~~2024 and ~~2022~~2023, we recognized revenue of $~~410~~90,~~000~~929 and $60410,~~067~~000, respectively, related to the performance obligations under product development service agreements with customers. These contracts are long term in nature and revenue is recognized at certain milestone intervals upon our delivery and customer acceptance of work product related to those milestones: namely, product design, packaging, branding display, and prototypes. There were no costs to obtain the contracts identified, and therefore, no asset has been recorded for customer acquisition costs. We have not recognized impairment losses related to the receivables from these contracts during the years ended December 31, ~~2023~~2024 and ~~2022~~2023.

Additionally, we recognized revenues of $1,~~206~~205,~~148~~867 and $1,~~659~~206,~~291~~148 during the years ended December 31, ~~2023~~2024 and ~~2022~~2023, respectively, related to the delivery of products to our customers. Each delivery is based on the unique contract with the customer, which is a stand-alone contract that we retain the right to accept or reject. Upon acceptance, we oblige delivery of such product to the customer at an agreed-upon place, time, and price. We recognize revenue under the unique contract upon fulfillment of our performance obligations therein, typically limited to the delivery of product.

The Company also recognizes revenue from advanced royalty payments per the terms in its Manufacturing and Distribution Agreement with one of its distributors. The royalty to be received is calculated based on 8% of gross sales, with an annual minimum royalty paid upfront per calendar year for the term of the contract. There is a non-refundable $350,000 Minimum Royalty for FY 2023. The Company recognizes the minimum royalty and corresponding expense at the time of receipt.

Accounts Receivable

Revenues that have been recognized but not yet received are recorded as accounts receivable. ~~Losses~~The onCompany ~~receivables~~estimates ~~will~~credit belosses ~~recognized~~based ~~when~~on itthe isCurrent ~~more~~Expected ~~likely~~Credit ~~than~~Losses ~~not~~(CECL) ~~that~~model aas ~~receivable~~required ~~will~~by ~~not~~ASC ~~be collected~~326. AnThe allowance for ~~estimated~~credit ~~uncollectible~~losses ~~amounts~~is ~~will~~based beon ~~recognized~~a variety of factors, toincluding ~~reduce~~historical ~~the~~loss ~~amount~~experience, ~~receivable~~current toconditions, ~~its~~and ~~net~~reasonable ~~realizable~~and ~~value~~supportable ~~when~~forecasts ~~needed~~of future economic conditions. As of December 31, ~~2023~~2024 and ~~2022~~2023, the Company has recorded an allowance for doubtful accounts of $04,839 and $390,~~438,~~ respectively.

Investment in Securities

Our cost-method investment consists of an investment in a private digital multi-media technology company that totaled $~~300~~248,000 and $300,000 at December 31, ~~2023~~2024 and ~~2022~~2023, respectivley. Because we owned less than 20% of that company’s stock as of each date, and no significant influence or control exists, the investment is accounted for using the cost method. Pursuant to ASC 321, the Company also searched for observable transactions in the investee’s stock and found none. We evaluated the investment for impairment and determined ~~there~~that the investment was ~~none~~impaired as of December 31, 2024. We ~~during~~recognized ~~the~~a ~~periods~~loss ~~presented~~on an impairment of $52,000 as of December 31, 2024.

Inventories

Inventories are stated at the lower of average cost or net realizable value. Cost on manufactured inventories includes labor, material, and overhead. Overhead cost is based on indirect costs allocated to cost of sales, work-in-process inventory, and finished goods inventory. Indirect overhead costs have been charged to cost of sales or capitalized as inventory, based on management’s estimate of the benefit of indirect manufacturing costs to the manufacturing process.

F-8

When there is evidence that the inventory’s value is less than original cost, the inventory is reduced to market value. We determine market value on current resale amounts and whether technological obsolescence exists. We will seek agreements with manufacturing customers that require them to purchase their inventory items in the event they cancel their business with us.

~~From time to time, we will place deposits on inventory to be delivered in the future. These deposits are carried as a separate balance sheet component and total $26,983 (non~~F-~~related-party) and $224,411 (related-party) as of December 31, 2023 and $40,440 (non-related-party) and $417,633 (related-party) as of December 31, 2022.~~8

From time to time, we will place deposits on inventory to be delivered in the future. These deposits are carried as a separate balance sheet component and total $28,803 (non-related-party) and $637 (related-party) as of December 31, 2024 and $26,983 (non-related-party) and $224,411 (related-party) as of December 31, 2023.

On most of tobacco related products, the Company pays in advance for Federal Excise Taxes and State Excise Taxes prior to receiving product. The Company accrues those taxes on its balance sheet and expenses them per-unit basis as sold.

Inventory balances consisted of the following:

SCHEDULE OF INVENTORY

	December 31, 2023		December 31, 2022
	December 31, 2024		December 31, 2023
Finished goods	$	~~772~~673,~~589~~866	$	~~787~~772,~~671~~589
Raw materials		4363,~~023~~357		2843,~~343~~023
Total	$	~~815~~737,~~612~~223	$	~~816~~815,~~014~~612

Fair Value of Financial Instruments

ASC 820-10-15, Fair Value Measurement-Overall-Scope and Scope Exceptions, defines fair value, thereby eliminating inconsistencies in guidance found in various prior accounting pronouncements, and increases disclosures surrounding fair value calculations. ASC 820-10-15 establishes a three-tiered fair value hierarchy that prioritizes inputs to valuation techniques used in fair value calculations. The three levels of inputs are defined as follows:

Level 1—Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2—Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3—Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

Accounts payable and related-party payables have fair values that approximate the carrying value due to the short-term nature of these instruments. Derivative liabilities are measured using level 3 inputs.

SCHEDULE OF FINANCIAL ASSETS AND LIABILITIES CARRIED AT FAIR ~~VALUED~~VALUE MEASURED ON RECURRING BASIS

Total Fair Value at December 31, 2023

Quoted prices in active markets (Level 1)

Significant other observable inputs (Level 2)

Significant unobservable inputs(Level 3)

Total Fair Value at December 31, 2024

Quoted prices in active markets (Level 1)

Significant other observable inputs (Level 2)

Significant unobservable inputs (Level 3)

Derivative liabilities

12,~~296~~458,~~937~~435

—

12,~~296~~458,~~937~~435

Total Fair Value at December 31, 2022

Quoted prices in active markets (Level 1)

Significant other observable inputs (Level 2)

Significant unobservable inputs (Level 3)

Total Fair Value at December 31, 2023

Quoted prices in active markets (Level 1)

Significant other observable inputs (Level 2)

Significant unobservable inputs (Level 3)

Derivative liabilities

1,~~004~~296,~~837~~937

—

1,~~004~~296,~~837~~937

F-9

Loss per Share

Basic loss per share is calculated by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during each period. Diluted loss per share is similarly calculated, except that the weighted-average number of common shares outstanding would include common shares that may be issued subject to existing rights with dilutive potential when applicable. There were approximately ~~216~~472,~~834~~076,000 and ~~106~~216,~~623~~834,~~280~~000 potentially issuable shares from the conversions of convertible debentures outstanding that were excluded in dilutive outstanding shares for the years ended December 31, ~~2023~~2024 and ~~2022~~2023, respectively, due to the anti-dilutive effect these would have on net loss per share. We do not currently have adequate authorized but unissued shares to satisfy our obligations should all instruments eligible to convert to common stock be exercised. We are not currently contemplating an increase in our authorized shares but may do so in the future.

Income Taxes

Income taxes are provided for the tax effects of the transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to tax net operating loss carryforwards. The deferred tax assets and liabilities represent the future tax return consequences of these differences, which will either be taxable or deductible when assets and liabilities are recovered or settled, as well as operating loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is established against deferred tax assets when in the judgment of management, it is more likely than not that such deferred tax assets will not become available. Because the judgment about the level of future taxable income is dependent to a great extent on matters that may, at least in part, be beyond our control, it is at least reasonably possible that management’s judgment about the need for a valuation allowance for deferred taxes could change in the near term.

Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely to be realized upon settlement. A liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in our tax returns that do not meet these recognition and measurement standards. As of December 31, ~~2023~~2024 and ~~2022~~2023, no liability for unrecognized tax benefits was required to be reported.

Recently Issued Accounting Pronouncements

The Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, in November 2023. This update enhances segment reporting disclosures to provide investors with more useful and transparent information about a company’s operating segments. Public companies must now disclose significant segment expenses that are regularly reviewed by the chief operating decision-maker (CODM). These expenses should be reported on an itemized basis, providing more insight into segment profitability. Companies must provide segment disclosures in both annual and interim reports. Required disclosures apply to all public entities under FASB’s segment reporting rules. Effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted.

The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company’s financial reporting, the Company undertakes a study to determine the consequences of the change to its Consolidated Financial Statements and assures that there are proper controls in place to ascertain that the Company’s Consolidated Financial Statements properly reflect the change.

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year.

In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. ASU 2023-09 is effective for annual periods beginning after December 15, 2024; early adoption is permitted. The Company does note expect the updated guidance to have a material impact on its disclosures.

In December 2023, the FASB issued ASU 2023-08, Intangibles - Goodwill and Other - Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets, which establishes accounting guidance for crypto assets meeting certain criteria. Bitcoin meets this criteria. The amendments require crypto assets meeting the criteria to be recognized at fair value with changes recognized in net income each reporting period. Upon adoption, a cumulative-effect adjustment is made to the opening balance of retained earnings as of the beginning of the annual reporting period of adoption. ASU 2023-08 is effective for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. Early adoption is permitted. The Company elected to early adopt ASU 2023-08 for the year ended December 31, 2023. The updated guidance is not expected to have a material impact on the Company’s disclosures.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 is intended to enhance reportable segment disclosures by requiring disclosures of significant segment expenses regularly provided to the CODM, requiring disclosure of the title and position of the CODM and explanation of how the reported measures of segment profit and loss are used by the CODM in assessing segment performance and allocation of resources. ASU 2023-07 is effective for the Company for annual periods beginning after December 31, 2023; early adoption is permitted. The updated guidance is not expected to have a material impact on the Company’s disclosures.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which was codified with its subsequent amendments as Accounting Standards Codification (“ASC”) Topic 326, Financial Instruments – Credit Losses (“ASC 326”). ASC 326 seeks to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments, including trade receivables, and other commitments to extend credit held by a reporting entity at each reporting date. The amendments require an entity to replace the incurred loss impairment methodology in other GAAP with a methodology that reflects current expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The updated guidance is effective for the Company for annual reporting periods beginning after December 15, 2022, and early adoption is permitted. The updated guidance is not expected to have a material impact on the Company’s disclosures.

NOTE 3 — GOING CONCERN

The accompanying consolidated financial statements have been prepared in conformity with US GAAP, which ~~contemplates~~considers our continuation as a going concern. We had a working capital deficiency of $1921,~~329~~839,~~094~~245, as of December 31, ~~2023~~2024, and a net loss from continuing operations of $~~543~~2,~~166~~ 547,354 for the year ended December 31, ~~2023~~2024. As of December 31, ~~2023~~2024, we had an accumulated deficit of $5961,~~017~~644,~~191~~067. These conditions raise substantial doubt about our ability to continue as a going concern.

Our ability to continue as a going concern is dependent upon our ability to successfully accomplish our business plan and eventually attain profitable operations. The accompanying unaudited consolidated financial statements do not include any adjustments that may be necessary if we are unable to continue as a going concern.

In the coming year, our foreseeable cash requirements will relate to development of business operations and associated expenses. We may experience a cash shortfall and be required to raise additional capital.

Historically, we have mainly relied upon shareholder loans and advances to finance operations and growth. Management may raise additional capital by retaining net earnings, if any, or through future public or private offerings of our stock or loans from private investors, although we cannot assure that we will be able to obtain such financing. Our failure to do so could have a material and adverse effect upon our shareholders and us.

F-10

Our ability to continue as a going concern is dependent upon our ability to successfully accomplish our business plan and eventually attain profitable operations. The accompanying consolidated financial statements do not include any adjustments that may be necessary if we are unable to continue as a going concern.

In the coming year, our foreseeable cash requirements will relate to the development of business operations and associated expenses. We may experience a cash shortfall and be required to raise additional capital.

NOTE 4 — PROPERTY AND EQUIPMENT

We incur certain costs associated with the design and development of molds and dies for our contract-manufacturing segment. These costs are held as deposits on the balance sheet until the molds or dies are finished and ready for use. At that point, the costs are included as part of production equipment in property and equipment and are amortized over their useful lives. We hold title to all molds and dies used in the manufacture of products.

Property and equipment and estimated service lives consist of the following:

December 31, 2023

December 31, 2022

Useful Life (years)

December 31, 2024

December 31, 2023

Useful Life (years)

Furniture and office equipment

12,212

312,~~798~~212

5-10

~~5-10~~

Vehicles

~~18,672~~–

18,672

3-7

~~3-7~~

Total

3012,~~884~~212

2230,~~470~~884

Less: accumulated depreciation

(115,~~959~~805

)

(711,~~452~~959

)

Property and equipment, net

186,~~925~~407

1518,~~018~~925

We recorded $4,~~508~~340 and $34,~~881~~507 of depreciation expense during the years ended December 31, ~~2023~~2024 and ~~2022~~2023.

During the year ended December 31, 2024, the Company sold its vehicle resulting in a gain on disposal of $7,222.

NOTE 5 — RELATED PARTY TRANSACTIONS

In 2007, we issued a 10% promissory note to a family member of our president in exchange for $300,000. The note was due on demand after May 2008. There were no repayments made during the periods presented. At December 31, ~~2023~~2024 and ~~2022~~2023, the principal amount owing on the note was $151,833 and $151,833, respectively. No demand for payment has been made.

On March 31, 2008, we issued to this same family member, along with two other company shareholders, promissory notes totaling $315,000 ($105,000 each). Under the terms of these three $105,000 notes, we received total proceeds of $300,000 and agreed to repay the amount received plus a 5% borrowing fee. The notes were due April 30, 2008, after which they were due on demand, with interest accruing at 12% per annum. We made no payments towards the outstanding notes during the periods presented. The principal balance owing on the notes as of December 31, ~~2023~~2024 and ~~2022~~2023, was $72,466 and $72,466, respectively. No demand for payment has been made.

There were $2119,~~882~~952 and $21,882 of short-term advances due to related parties as of December 31, ~~2023~~2024 and ~~2022~~2023, respectively.

We have agreed to issue stock options to Iehab Hawatmeh, our president, as compensation for services provided as our chief executive officer. The terms of his employment agreement require us to grant options to purchase 6,000 shares of our stock each year, with an exercise price of $0.10. Mr. Hawatmeh held outstanding options to purchase 30,000 shares of common stock as of December 31, 2023. See Note 13–Stock Options and Warrants.

As of December 31, 2023 and 2022, we owed our president a total of $433,379 and $433,379, respectively, in unsecured advances. The advances and short-term bridge loans were approved by our board of directors under a 5% borrowing fee. The borrowing fees were waived by our president on these loans. These amounts are included in our liabilities from discontinued operations.

As of December 31, 2023 and 2022, we owed a total of $0 and $13,740, respectively, to a related party through trade payables incurred in the normal course of business. These amounts are shown as a separate related-party payable on the balance sheet as of each reporting date.

During the year ended December 31, 2023, we had a net decrease in deposits with a related-party inventory supplier totaling $193,222. The related party is an entity controlled by our chief executive officer. All transactions were at a 2% markup over the related-party’s cost paid for inventory in arm’s-length transactions. Total inventory purchases from the related party were $837,618 and $341,734 during the periods ended December 31, 2023 and 2022, respectively.

F-11

We have previously agreed to issue stock options to Iehab Hawatmeh, our president, as compensation for services provided as our chief executive officer. The terms of his employment agreement require us to grant options to purchase 6,000 shares of our stock each year. Mr. Hawatmeh held outstanding options to purchase 24,000 shares of common stock as of December 31, 2024. See Note 11–Stock Options and Warrants.

As of December 31, 2024 and 2023, we owed our president a total of $433,379 and $433,379, respectively, in unsecured advances. The advances and short-term bridge loans were approved by our board of directors under a 5% borrowing fee. The borrowing fees were waived by our president on these loans. These amounts are included in our liabilities from discontinued operations.

As of December 31, 2024, the Company owes the CEO $7,059 for short term advances to the Company. The advances are non-interest bearing and due on demand.

During the years ended December 31, 2024 and 2023, we had a net decrease in deposits with a related-party inventory supplier totaling $223,774 and $193,222, respectively. The related party is an entity controlled by our chief executive officer. All transactions were at a 2% markup over the related-party’s cost paid for inventory in arm’s-length transactions. Total inventory purchases from the related party were $1,168,930 and $837,618 during the periods ended December 31, 2024 and 2023, respectively.

NOTE 6 — OTHER ACCRUED LIABILITIES

Accrued tax liabilities consist of delinquent payroll taxes, interest, and penalties owed by us to the Internal Revenue Service (“IRS”) and other tax entities.

Accrued liabilities consist of the following:

	December 31, 2023		December 31, 2022
	December 31, 2024		December 31, 2023
Tax liabilities	$	3766,~~228~~456	$	~~548~~37,~~811~~228
Accrued Royalty - Globrands LLC		1854,~~092,915~~498		—1,092,915
Other		1,~~759~~855,~~246~~054		1,~~530~~759,~~441~~246
Total	$	2,~~889~~776,~~389~~008	$	2,~~079~~889,~~252~~389

Other accrued liabilities as of December 31, ~~2023~~2024 and ~~2022~~2023, include a non-interest-bearing payable totaling $45,000 and $45,000, respectively, that is due on demand and customer deposits totaling $1,~~735~~730,~~109~~213 and $1,~~437~~735,~~361~~109, respectively.

Accrued payroll and compensation liabilities consist of the following:

	December 31, 2023		December 31, 2022
	December 31, 2024		December 31, 2023
Director fees	$	135,000	$	135,000
Bonus expenses		121,858		121,858
Commissions		2,148		2,148
Consulting		~~438~~412,~~822~~322		~~500~~438,~~322~~822
Administrative payroll		4,~~369~~710,~~385~~221		4,~~035~~369,~~508~~385
Total	$	5,~~067~~381,~~213~~549	$	45,~~794~~067,~~836~~213

NOTE 7 — COMMITMENTS AND CONTINGENCIES

Litigation and Claims

Various vendors, service providers, and others have asserted legal claims in previous years. These creditors generally are not actively seeking collection of amounts due to them, and we have determined that the probability of realizing any loss on these claims is remote and will seek to compromise and settle at a deep discount any of such claims that are asserted for collection. These amounts are included in our current liabilities, except where we believe collection or enforcement of the judgments is barred by the applicable statute of limitations, in which case the liabilities have been eliminated. We have not accrued any liability for claims or judgments that we have determined to be barred by the applicable statute of limitations, which generally is eight years for judgments in Utah.

F-12

Playboy Enterprises, Inc.

Our affiliate, Play Beverages, LLC, filed suit against Playboy Enterprises, Inc., in Cook County, Illinois, Circuit Court in October 2012 asserting numerous claims, including breach of contract and tortious interference. Playboy responded with a counterclaim of breach of contract and trademark infringement. After proceedings in October 2016, the court awarded a judgment of $6.6 million to Playboy against Play Beverages and CirTran Beverage Corp., our subsidiary. The court denied our motion for a new trial and awarded Playboy treble patent infringement damages and attorney’s fees. We filed a notice of appeal in July 2017 and again in March 2018. Playboy has initiated collection efforts but has recovered no funds. In September 2018, the appellate court affirmed the judgment of the circuit court. The balance due related to this judgment, has been included in liabilities in discontinued operations. As of December 31, 2023, the Company received legal representation that the judgement can no longer be enforced after seven years, as a result, the Company has recognized a gain from discontinued operations of $18,878,359 of time barred debt previously included in liabilities from discontinued operations.

Delinquent Payroll Taxes, Interest, and Penalties

In November 2004, the IRS accepted our amended offer in compromise (the “Offer”) to settle delinquent payroll taxes, interest, and penalties, which required us to pay $500,000, remain current in our payment of taxes for five years, and forego claiming any net operating losses for the years 2001 through 2015 or until we paid taxes on future profits in an amount equal to the taxes of $1,455,767 waived by the Offer. In June 2013, we entered into a partial installment agreement to pay $768,526 in unpaid 2009 payroll taxes, which required us to pay the IRS 5% of cash deposits. The monthly payments were to continue until the account balances were paid in full or until the collection statute of limitation expired on October 6, 2020. We are currently in communication with the IRS regarding the statute of limitations on this settlement and appropriate next steps. During the year ended December 31, 2023, the Company wrote off $512,520 as time barred debt. The amounts of $5,164 and $~~517~~5,~~684~~ 164 were due as December 31, ~~2023~~2024 and ~~2022~~2023, respectively.

Employment Agreements

We engage Iehab Hawatmeh, our president and chief executive officer, through an employment agreement entered in August 2009 and amended in September 2017. In July 2017, Mr. Hawatmeh had resigned all positions with us to pursue other business activities, thereby effectively terminating the agreement. However, the amendment to his employment agreement in September 2017 reinstated Mr. Hawatmeh to his previous positions, with a salary in an amount to be determined. Among other things, the reinstated employment agreement: (a) grants options to purchase a minimum of 6,000 shares of our stock each year, with an exercise price equal to the market price of our common stock as of the grant date, for the maximum term allowed under our stock option plan; (b) provides for health insurance coverage, cell phone, car allowance, life insurance, and director and officer liability insurance, as well as any other bonus approved by our board; and (c) includes additional incentive compensation as follows: (i) a quarterly bonus equal to 5% of our earnings before interest, taxes, depreciation, and amortization for the applicable quarter; (ii) bonuses equal to 1% of the net purchase price of any acquisitions we complete that are directly generated and arranged by Mr. Hawatmeh; and (iii) an annual bonus (payable quarterly) equal to 1% of our gross sales of all products, net of returns and allowances. On January 1, 2020, we resumed accruing wages for our chief executive officer. A total of $345,000 and $345,000 was accrued during the ~~period~~periods ended December 31, ~~2023~~2024 and ~~2022~~2023, respectively.

We also have an oral agreement with our other director that requires us to issue options to purchase 2,000 shares of our common stock each year.

License Agreements

We have entered into agreements requiring us to pay certain royalties for the manufacture and distribution of licensed products. Fees are based on a percentage of sales and remitted quarterly and are included in cost of sales for financial reporting purposes.

F-13

NOTE 8 — NOTES PAYABLE

Notes payable consisted of the following:

	December 31, 2023		December 31, 2022
	December 31, 2024		December 31, 2023
Note payable to former service provider for past due account payable (current)	$	90,000	$	90,000
Note payable for settlement of debt (long-term)		500,000		500,000
Small Business Administration loan		134,636		143,000
Small Business Administration loans		143,000		134,636
Total	$	~~724~~733,~~636~~000	$	~~733~~724,~~000~~636

There is $~~366~~402,~~626~~906 and $~~313~~366,~~764~~626 of accrued interest due on these notes as of December 31, ~~2023~~2024 and ~~2022~~2023, respectively.

F-13

NOTE 9 — CONVERTIBLE DEBENTURES

Convertible debentures consisted of the following:

	December 31, 2023			December 31, 2022
	December 31, 2024			December 31, 2023
Convertible debenture, 5% stated interest rate, secured by all our assets, due on May 30, 2022	$	200,000		$	200,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on February 8, 2022		25,000			25,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on May 30, 2022		25,000			25,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on December 8, 2022		25,000			25,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on April 30, 2027		2,390,528			2,390,528
Subtotal	$	2,665,528		$	2,665,528
Less: discounts		(323,310	)		(432,934	)
Debt carrying amount	$	2,665,528		$	2,665,528
Total	$	2,342,218		$	2,232,594
Less: discounts		(223,521	)		(323,310	)
Total	$	2,442,007		$	2,342,218
Less: current portion		(264,284	)		(264,284	)
Long-term portion	$	2,~~077~~177,~~934~~723		$	12,~~968~~077,~~310~~934

The convertible debentures and accrued interest are convertible into shares of our common stock at the lower of $100 or the lowest bid price for the 20 trading days prior to conversion.

As of December 31, ~~2023~~2024 and ~~2022~~2023, we had accrued interest on the convertible debentures totaling $12,~~921~~055,~~590~~232 and $1,~~788~~921,~~318~~590, respectively.

NOTE 10 — DERIVATIVE LIABILITIES

As discussed in Note 9—Convertible Debentures, we have entered into five separate agreements to borrow a total of $2,665,528 with the outstanding principal and interest being convertible at the holder’s option into common stock of the company at the lesser of $100 (notes one through four) or $0.10 (note five) or the lowest closing bid price in the prior 20 trading days. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in our balance sheet. We measure these instruments at their estimated fair value and recognize changes in their estimated fair value in results of operations during the period of change. We have estimated the fair value of these embedded derivatives for convertible debentures and associated warrants using a Monte Carlo simulation as of December 31, ~~2023~~2024, using the following assumptions:

Volatility	136.0% - 139.62	~~119.8% - 127.6~~	%
Risk-free rates		4.6009% - 4.7913	%
Stock price	$	0.~~023~~01999
Remaining life		0.25- 32.33 years

The fair values of the derivative instruments are measured each quarter, which resulted in a loss of $292,100 and $66,040 during the year ended December 31, 2023 and 2022, respectively. As of December 31, 2023 and December 31, 2022, the fair market value of the derivatives aggregated $1,296,937 and $1,004,837, respectively.

F-14

~~NOTE~~A 11summary —of ~~INCOME~~the ~~TAXES~~activity of the derivative liability for these notes is as follows:


Balance at December 31, 2022	$	1,004,837
Derivative loss due to mark to market adjustment		292,100
Balance at December 31, 2023		1,296,937
Balance		1,296,937
Derivative loss due to mark to market adjustment		1,161,498
Balance at December 31, 2024	$	2,458,435
Balance	$	2,458,435

The fair values of the derivative instruments are measured each quarter, which resulted in a loss of $1,161,498 and $292,100 during the years ended December 31, 2024 and 2023, respectively. As of December 31, 2024 and 2023, the fair market value of the derivatives aggregated $2,458,435 and $1,296,937, respectively.

NOTE 11 — STOCK OPTIONS AND WARRANTS

Stock Incentive Plans

As of December 31, 2024 and 2023, we had no unrecognized compensation related to outstanding options that have not yet vested at year-end that would be recognized in subsequent periods.

As of December 31, 2024 and 2023, there were 32,000 and 40,000 options, respectively, issued and vested with a weighted average exercise price of $0.01. Outstanding options as of December 31, 2024, consisted of:

	Number of Options			Weighted Average Exercise Price		Average Remaining Life
Outstanding, December 31, 2023		40,000		$	0.01		2.94
Issued		—		$	—		—
Cancelled		(8,000	)	$	—		—
Exercised		—		$	—		—
Outstanding, December 31, 2024		32,000		$	0.01		1.52
Exercisable, December 31, 2024		32,000		$	0.01		1.52

NOTE 12 — SEGMENTS

The Company uses ASC 280, Segment Reporting, in determining its reportable segments. The Company has two reportable segments based on sales: Tobacco products and all other sources of revenue. The guidance requires that segment disclosures present the measure(s) used by the Chief Operating Decision Maker (“CODM”) to decide how to allocate resources and for purposes of assessing such segments’ performance. The Company’s CODM is comprised of its executive management team who use revenue and expenses of the two reporting segments to assess the performance of the business of our reportable operating segments.

F-15

The following table details revenue, operating expenses, and assets for the Company’s reportable segments for the year ended December 31, 2024.

	Tobacco Line			All other product lines			Total
ASSETS
Current Assets:
Cash	$	—		$	—		$	—
Inventory		641,919			95,304			737,223
Deposits on inventory		—			28,803			28,803
Deposits on inventory - related party		637			—			637
Deposits on inventory		637			—			637
Accounts receivable		—			25,641			25,641
Other current assets		—			485,621			485,621
Total current assets		642,556			635,369			1,277,925
Investment in securities at cost		—			248,000			248,000
Property and equipment, net of accumulated depreciation		—			6,407			6,407
Total assets	$	642,556		$	889,776		$	1,532,332

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	244,524		$	517,916		$	762,440
Cash overdraft		—			30,384			30,384
Liabilities for product returns and credits		61,353			8,701			70,054
Short-term advances payable		—			162,966			162,966
Short-term advances payable - related parties		—			22,452			22,452
Short-term advances payable		—			22,452			22,452
Accrued liabilities		1,397,825			1,378,183			2,776,008
Accrued payroll and compensation expense		4,391,000			990,549			5,381,549
Accrued interest, current portion		—			6,281,805			6,281,805
Convertible debenture, current portion, net of discounts		—			264,284			264,284
Note payable, current portion		—			90,000			90,000
Note payable to stockholders		—			151,833			151,833
Note payable		—			151,833			151,833
Derivative liability		—			2,458,435			2,458,435
Liabilities from discontinued operations		—			4,664,960			4,664,960
Total current liabilities:		6,094,702			17,022,468			23,117,170
Note payable, net of current portion		—			643,000			643,000
Convertible debenture, net of current portion, net of discount		—			2,177,723			2,177,723
Total liabilities		6,094,702			19,843,191			25,937,893

Stockholders’ Equity:
Common stock		—			4,945			4,945
Additional paid-in capital		—			37,233,561			37,233,561
Accumulated deficit		(5,452,146	)		(56,191,921	)		(61,644,067	)
Total stockholders’ equity		(5,452,146	)		(18,953,415	)		(24,405,561	)
Total liabilities and stockholders’ deficit	$	642,556		$	889,776		$	1,532,332

F-16

	Tobacco Line			All other product lines			Total
Revenue:
Net sales	$	1,056,862		$	239,934		$	1,296,796
Cost of sales		363,989			94,169			458,158
Gross profit		692,873			145,765			838,638

Operating expenses:
Employee costs		425,073			90,734			515,807
Selling, general and administrative expenses		717,827			155,743			873,570
Total operating expenses		1,142,900			246,477			1,389,377

Loss from operations		(450,027	)		(100,712	)		(550,739	)

Other income (expense):
Interest expense		—			(790,589	)		(790,589	)
Impairment of investment					(52,000	)		(52,000	)
Gain on disposal of equipment		—			7,222			7,222
Loss on derivative valuation		—			(1,161,498	)		(1,161,498	)
Other income		—			250			250
Total other expense		—			(1,996,615	)		(1,996,615	)
Net loss from continuing operations		(450,027	)		(2,097,327	)		(2,547,354	)
Loss from discontinued operations		—			(153,886	)		(153,886	)
Net Loss before income tax		(450,027	)		(2,251,213	)		(2,701,240	)
Income tax		—			74,364			74,364
Net Loss	$	(450,027	)	$	(2,176,849	)	$	(2,626,876	)

NOTE 13 — INCOME TAXES

We did not provide any current or deferred U.S. federal income tax provision or benefit for any of the periods presented because we have experienced operating losses since inception. When it is more likely than not that a tax asset cannot be realized through future income, the company must allow for this future tax benefit. We provided a full valuation allowance on the net deferred tax asset, consisting of net operating loss carryforwards, because management has determined that it is more likely than not that we will not earn income sufficient to realize the deferred tax assets during the carryforward period. The U.S. federal income tax rate of 21% is being used.

We have not taken a tax position that, if challenged, would have a material effect on the financial statements for the years ended December 31, ~~2023~~2024 and ~~2022~~2023, applicable under FASB ASC 740, Income Taxes. We did not recognize any adjustment to the liability for an uncertain tax position and, therefore, did not record any adjustment to the beginning balance of accumulated deficit on the balance sheet. All our tax returns remain open.

As of December 31, ~~2023~~2024 and ~~2022~~2023, we had net operating loss carryforwards for tax reporting purposes of approximately $36.81 million and $213.4 8 million, respectively. During the year ended December 31, 2019, we dissolved four subsidiaries that had total net operating loss ~~carryforwards~~ carryforwards of approximately $8.9 million, which were forfeited upon dissolution, reducing our deferred tax asset by approximately $1.9 million. In addition, the realization of tax benefits relating to net operating loss carryforwards is limited due to the settlement related to amounts previously due to the IRS, as discussed in Note 6 – Other Accrued Liabilities.

As of December 31, 2022, we recognized an accrual for tax liability expense of $50,888 for our LBC Products, Inc, subsidiary only. LBC is not considered part of the consolidated company for tax purposes.F-17

As of December 31, 2024 and 2023, we recognized a tax benefit of $74,364 and $8,533, respectively, for our LBC Products, Inc, subsidiary only. LBC is not considered part of the consolidated company for tax purposes.

	2023			2022
	2024			2023
Deferred Tax Assets:
NOL Carryover	$	1,~~177~~585,~~300~~600		$	51,~~461~~177,~~800~~300
Less valuation allowance		(1,~~177~~585,~~300~~600	)		(51,~~461~~177,~~800~~300	)
Net deferred tax assets	$	—		$	—

The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended December 31, ~~2023~~2024 and ~~2022~~2023 due to the following:

	2023			2022
	2024			2023
Book income (loss)	$	4(552,~~260,600~~900	)	$	~~(315~~4,~~400~~260,600	)
Change in payroll accruals		5766,~~200~~000			7457,200
Allowance for doubtful accounts		~~(8,300~~—	)		(8,300	)
Amortization of debt discount		2321,000			1923,~~255~~000
Change in derivative liability		61,300			13,868
Related party accruals		100			—
Valuation allowance		(4,393,800	)		199,777
Change in derivative liability		243,900			61,300
Valuation allowance		221,900			(4,393,800	)
Income tax expense	$	—		$	—

NOTE 1214 — ~~STOCK~~DISCONTINUED ~~OPTIONS AND WARRANTS~~OPERATIONS

~~Stock~~At ~~Incentive~~October ~~Plans~~21, 2016, we exited the beverage licensing and distribution business. The assets and liabilities associated with this business are displayed as assets and liabilities from discontinued operations as of December 31, 2024 and 2023. Additionally, the revenues and costs associated with this business are displayed as losses from discontinued operations.

During the year ended December 31, 2023, ~~8,000~~the ~~options~~Company ~~previously~~received ~~granted~~legal representation that the judgement related to ~~employees~~Play ~~expired.~~Beverages, ~~During~~LLC, ~~the~~(Note 7) ~~same~~can ~~period~~no welonger ~~granted~~be ~~those~~enforced ~~same employees~~after 8seven years,~~000~~ ~~new~~as ~~options~~a toresult, ~~purchase~~the ~~shares~~Company ofhas ~~common~~recognized ~~stock.~~a ~~The~~gain ~~value~~from ofdiscontinued ~~the~~operations ~~options~~of is$18,873,932 of ~~nominal;~~time ~~therefore~~barred ~~there~~debt ispreviously noincluded ~~current~~in ~~impact to~~liabilities ~~the~~from ~~financial~~discontinued ~~statements~~operations.

F-15

As of December 31, 2023 and 2022, we had no unrecognized compensation related to outstanding options that have not yet vested at year-end that would be recognized in subsequent periods.

As of December 31, 2023 and 2022, there were 40,000 options issued and vested with a weighted average exercise price of $0.03 and a weighted average remaining life of 1.68 years. Outstanding options as of December 31, 2023, consisted of:

SCHEDULE OF STOCK OPTIONS OUTSTANDING

Exercise Price		Count		Average Exercise		Remaining Life		Exercisable
$	0.01		32,000		0.01		2.48		32,000
$	0.10		8,000		0.10		4.75		8,000
	Total		40,000		0.03		2.94		40,000

NOTE 13—DISCONTINUED OPERATIONS

At October 21, 2016, we exited the beverage licensing and distribution business. The assets and liabilities associated with this business are displayed as assets and liabilities from discontinued operations as of December 31, 2023 and 2022. Additionally, the revenues and costs associated with this business are displayed as losses from discontinued operations.

As of December 31, 2023, the Company received legal representation that the judgement related to Play Beverages, LLC, (Note 7) can no longer be enforced after seven years, as a result, the Company has recognized a gain from discontinued operations of $18,873,932 of time barred debt previously included in liabilities from discontinued operations.

Total assets and liabilities included in discontinued operations were as follows:

	December 31, 2023		December 31, 2022
	December 31, 2024		December 31, 2023
Assets from Discontinued Operations:
Cash	$	—	$	—
Total assets from discontinued operations	$	—	$	—
Liabilities from Discontinued Operations:
Accounts payable	$	283,818	$	18283,~~338,848~~818
Accrued liabilities		58,184		~~589~~58,~~380~~184
Accrued interest		1,~~636~~790,~~624~~509		1,~~483~~636,~~157~~624
Accrued payroll and compensation expense		122,864		~~131~~122,~~108~~864
Current maturities of long-term debt		239,085		239,085
Related-party payable		—		1,776,250
Short-term advances payable		2,170,500		2,170,500
Short-term advances payable		2,170,500		2,784,773
Total liabilities from discontinued operations	$	4,664,960	$	4,511,075
Total liabilities from discontinued operations	$	4,511,075	$	25,342,601

Net ~~gain (~~loss) from discontinued operations for the years ended December 31, ~~2023~~2024 and ~~2022~~2023, were comprised of the following components:

	2023			2022
	2024			2023
	Years ended December 31,
	2023			2022
	2024			2023
Other income (expense):
Other expense:
Gain on settlement	$	~~18,878,359~~—		$	—18,878,359
Gain on Forgiveness of Debt		2,106,633			—
Gain on forgiveness of debt		—			2,106,633
Interest expense		(153,~~466~~886	)		(153,466	)
Net gain (loss) from discontinued operations	$	20,831,526		$	(153,466	)
Net loss from discontinued operations	$	(153,886	)	$	20,831,526

~~F-16~~NOTE 15 — SUBSEQUENT EVENTS

~~NOTE~~In 14accordance —with ~~SUBSEQUENT~~SFAS ~~EVENTS~~165 (ASC 855-10), management has performed an evaluation of subsequent events through the date that the consolidated financial statements were issued and has determined that it does not have any material subsequent events to disclose in these consolidated financial statements.

~~In accordance with SFAS 165 (ASC 855~~F-10), management has performed an evaluation of subsequent events through the date that the unaudited consolidated financial statements were issued and has determined that it does not have any material subsequent events to disclose in these unaudited consolidated financial statements.18

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of December 31, ~~2023~~2024, we carried out an evaluation, under the supervision and with the participation of management, including our principal executive and principal financial officer (whom we refer to in this periodic report as our Certifying Officer), of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, management concluded that our disclosure controls and procedures were not effective as of December 31, ~~2023~~2024, to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the periods prescribed by U.S. Securities and Exchange Commission and that such information is accumulated and communicated to management, including our Certifying Officer, as appropriate, to allow timely decisions regarding required disclosure.

Limitations on Effectiveness of Controls

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal controls, as defined in the Exchange Act. These internal controls are designed to provide reasonable assurance that the reported financial information is presented fairly, that disclosures are adequate and that the judgments inherent in the preparation of financial statements are reasonable. There are inherent limitations in the effectiveness of any system of internal controls, including the possibility of human error and overriding of controls. Consequently, an effective internal control system can only provide reasonable, not absolute, assurance with respect to reporting financial information.

Our internal control over financial reporting includes policies and procedures that: (i) pertain to maintaining records that in reasonable detail accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements in accordance with GAAP and the receipts and expenditures of company assets are made and in accordance with our management and directors authorization; and (iii) provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on our financial statements.

Management has undertaken an assessment of the effectiveness of our internal control over financial reporting based on the framework and ~~criteria~~ criteria established in the Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based upon this evaluation, management concluded that our internal control over financial reporting was not effective as of December 31, ~~2023~~2024.

1314

Based on that evaluation, management concluded that, during the period covered by this report, such internal controls and procedures were not effective due to the following material weakness identified:

	●	Lack of appropriate segregation of duties,

	●	Lack of control procedures that include multiple levels of supervision and review,

	●	Lack of financial resources to engage adequate external expertise; and

	●	Overreliance upon independent financial reporting consultants for review of critical accounting areas and disclosures and material, nonstandard transactions.

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to rules of the SEC that permit us to provide only the management’s report in this annual report.

Implemented or Planned Remedial Actions in Response to the Material Weaknesses

We will continue to strive to correct the above noted weakness in internal control once we have adequate funds to do so. We believe appointing a director who qualifies as a financial expert will improve the overall performance of our control over our financial reporting.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the year ended December 31, ~~2023~~2024, that materially affect, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Directors and Executive Officers

The names of our director and executive officers as of December 31, ~~2023~~2024, and their ages, positions, and biographies are set forth below. Our executive officers are appointed by, and serve at the discretion of, our board of directors.

Name	Age	Title	Tenure

Iehab Hawatmeh	58	President, Chief Executive Officer,	July 2000 to date
		Chief Financial Officer, Chairman
Kathryn Hollinger	74	Director, Controller	August 2011 to date

Name	Age	Title	Tenure
Iehab Hawatmeh	57	President, Chief Executive Officer,	July 2000 to date
		Chief Financial Officer, Chairman
Kathryn Hollinger	73	Director, Controller	August 2011 to date

Iehab J. Hawatmeh

Iehab J. Hawatmeh founded our predecessor company in 1993 and has been our chairman, president, and chief executive officer since July 2000, except for a brief absence during 2017. Mr. Hawatmeh oversees all daily operations, including our technical and sales functions. Mr. Hawatmeh is currently functioning in a dual role as chief financial officer. Before his involvement with our company, Mr. Hawatmeh was the Processing Engineering Manager for Tandy Corporation, Salt Lake City, Utah, overseeing that company’s contract manufacturing printed circuit board assembly division. In addition, he was responsible for developing and implementing Tandy’s facility Quality Control and Processing Plan model. Mr. Hawatmeh earned an MBA from University of Phoenix and a BS in Electrical and Computer Engineering from Brigham Young University.

Kathryn Hollinger

Kathryn Hollinger has been with CirTran since 2000 as our controller, except for a brief period during 2017 in which she also acted as chief executive officer. She has been involved with the day-to-day accounting and finance functions throughout her term with us. Ms. Hollinger studied mathematics and accounting at Northridge University (now Cal. State University Northridge) in California.

Election of Directors and Officers

Directors are elected to serve until the next annual meeting of stockholders and until their successors have been elected and qualified. Officers are appointed to serve until the meeting of the board of directors following the next annual meeting of stockholders and until their successors have been elected and qualified.

Committees of the Board

We currently do not have nominating, compensation, or audit committees or committees performing similar functions and we do not have a written nominating, compensation, or audit committee charter. Our board of directors believes that it is not necessary to have these committees, at this time, because the directors can adequately perform the functions of such committees.

Family Relationships

There are no family relationships among any of our officers or directors.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Exchange Act requires our directors, executive officers, and persons that own more than 10% of a registered class of our equity securities to file with the U.S. Securities and Exchange Commission initial reports of ownership and reports of changes in ownership of our equity securities. Officers, directors, and greater than 10% stockholders are required to furnish us with copies of all Section 16(a) forms they file.

Based solely upon a review of Forms 3, 4, and 5 and amendments thereto filed with the U.S. Securities and Exchange Commission for the year ended December 31, ~~2023~~2024, no person that, at any time during the most recent fiscal year, was a director, officer, beneficial owner of more than 10% of any class of our equity securities, or any other person known to be subject to Section 16 of the Exchange Act failed to file, on a timely basis, reports required by Section 16(a) of the Exchange Act, except that two officers failed to report options earned and options that expired during the fiscal year.

Code of Ethics

We expect that all directors, officers, and employees will maintain a high level of integrity in their dealings with us and on our behalf and will act in our best interests. We have adopted a Code of Business Conduct and Ethics that provides principles of conduct and ethics for our directors, officers, and employees. This Code of Ethics is available on our website at www.cirtran.com under “Investor Relations—Corporate Governance.”

ITEM 11. EXECUTIVE COMPENSATION

Summary Compensation Table

The following table sets forth, for each of our last two completed fiscal years, the dollar value of all cash and noncash compensation earned by any person who was our principal executive officer and each of our three most highly compensated other executive officers or persons who were serving in such capacities during the preceding fiscal year (“Named Executive Officers”):

Name and Principal Position	Year Ended Dec. 31		Salary ($)		Bonus ($)		Stock Award(s) ($)		Option Awards ($)(1)			Non Equity Incentive Plan Compen- sation		Change in Pension Value and Non- Qualified Deferred Compen- sation Earnings ($)		All Other Compen- sation ($)			Total ($)
(a)	(b)		(c)		(d)		(e)		(f)			(g)		(h)		(i)			(j)
Iehab J. Hawatmeh(1)		~~2023~~2024		345,000		-		-		~~139~~-	~~(2)~~		-		-		15,600	(3)		360,~~739~~600
President, Chief Executive Officer		~~2022~~2023		345,000		-		-		~~293~~139	(2)		-		-		15,600	(3)		360,~~893~~739
Kathryn Hollinger(4)		~~2023~~2024		55,000		-		-		46-	~~(2)~~		-		-		5,000	(5)		60,~~046~~000
		2022		55,000		-		-		98	(2)		-		-		5,000	(5)		60,098
		2023		55,000		-		-		46	(2)		-		-		5,000	(5)		60,046

	(1)	Mr. Hawatmeh accrued $~~297~~271,~~000~~790 and $~~345~~297,000 of his salary in ~~2023~~2024 and ~~2022~~2023.
	(2)	The amount is the fair value of the option awards on the date of grant in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718. See note 2 to our consolidated financial statements.
	(3)	Includes $12,000 for car allowance for each of ~~2023~~2024 and ~~2022~~2023 and $3,600 and $3,600 for medical insurance premiums for ~~2023~~2024 and ~~2022~~2023.
	(4)	Ms. Hollinger’s compensation listed in this table is for her services as our controller.
	(5)	Fees accrued as director compensation.

Employment Agreements—Change in Control

We engage Iehab Hawatmeh, our president and chief executive officer, through an employment agreement entered in August 2009 and amended in September 2017, with a salary in an amount and commencement date to be determined. In July 2017, Mr. Hawatmeh resigned all positions with us to pursue other business activities, thereby effectively terminating the agreement. However, in September 2017, we reinstated Mr. Hawatmeh to his previous positions and reinstated his employment agreement. Among other things, the reinstated employment agreement: (a) grants options to purchase a minimum of 6,000 shares of our stock each year, with an exercise price equal to the market price of our common stock as of the grant date, for the maximum term allowed under our stock option plan; (b) provides for health insurance coverage, cell phone, car allowance, life insurance, and director and officer liability insurance, as well as any other bonus approved by our board; (c) includes additional incentive compensation as follows: (i) a quarterly bonus equal to 5% of our earnings before interest, taxes, depreciation and amortization for the applicable quarter; (ii) bonuses equal to 1% of the net purchase price of any acquisitions we complete that are directly generated and arranged by Mr. Hawatmeh; and (iii) an annual bonus (payable quarterly) equal to 1% of our gross sales of all products, net of returns and allowances. All cash amounts payable to Mr. Hawatmeh more than an aggregate of $120,000 per year are accrued and will not be paid until the secured convertible debenture is paid or converted to common stock.

1617

Pursuant to the employment agreement, Mr. Hawatmeh’s employment may be terminated for cause, or upon death or disability, in which event we are required to pay him any unpaid base salary and unpaid earned bonuses. In the event that Mr. Hawatmeh is terminated without cause, we are required to pay to him: (i) within 30 days following such termination, any benefit, incentive, or equity plan, program, or practice paid when such would have been paid to him if employed (the “Accrued Obligations”); (ii) within 30 days following such termination (or on the earliest later date as may be required by Internal Revenue Code Section 409A to the extent applicable), a lump sum equal to 30 months’ annual base salary; (iii) bonuses owing for the two-year period after the date of termination (net of any bonus amounts paid as Accrued Obligations) based on actual results for the applicable quarters and fiscal years; and (iv) within 12 months following such termination (or on the earliest later date as may be required by Internal Revenue Code Section 409A to the extent applicable), a lump sum equal to 30 months’ annual base salary; provided that if Mr. Hawatmeh is terminated without cause in contemplation of, or within one year, after a change in control, then two times his annual base salary and bonus payment amounts.

During the years ended December 31, ~~2023~~2024 and ~~2022~~2023, we accrued ~~6,000~~0 and 6,000 stock options, respectively, relating to this employment agreement. The fair market value of the options issued during the years ended December 31, 2023 ~~and~~awas ~~2022 was~~ $139 ~~and $293, respectively~~.

Outstanding Equity Awards at Fiscal Year End

The following table summarizes information regarding unexercised options, stock that has not vested, and equity incentive plan awards owned by the Named Executive Officers as of December 31, ~~2023~~2024:

Name	Number of Securities Underlying Unexercised Options (#) Exercisable		Number of Securities Underlying Unexercised Options (#) Unexer- cisable(1)		Equity Incentive Plan Awards: Number of Securities Underlying Unexer- cised Unearned Options(#)		Option Exercise Price($)		Option Expiration Date		Number of Shares or Units of Stock Held That Have Not Vested(#)		~~Number of Shares or Units of Stock Held That Have Not Vested(#)~~		Market Value of Shares or Units of Stock That Have Not Vested($)		~~Market Value of Shares or Units of Stock That Have Not Vested($)~~		Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested(#)		~~Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested(#)~~		Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested($)		~~Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested($)~~
Iehab Hawatmeh		—		6,000		—		0.1001	01/06/25	~~04/01/24~~		—		—		—		—		—		—		—		—
Kathryn Hollinger		—		2,000		—		0.1001	01/06/25	~~04/01/24~~		—		—		—		—		—		—		—		—
Iehab Hawatmeh		—		6,000		—		0.01	01/06/26	~~01/06/25~~		—		—		—		—		—		—		—		—
Kathryn Hollinger		—		2,000		—		0.01	01/06/26	~~01/06/25~~		—		—		—		—		—		—		—		—
Iehab Hawatmeh		—		6,000		—		0.01	01/03/27	~~01/06/26~~		—		—		—		—		—		—		—		—
Kathryn Hollinger		—		2,000		—		0.01	01/03/27	~~01/06/26~~		—		—		—		—		—		—		—		—
Iehab Hawatmeh		—		6,000		—		0.01	01/03/28	~~01/03/27~~		—		—		—		—		—		—		—		—
Kathryn Hollinger		—		2,000		—		0.01	01/03/28	~~01/03/27~~		—		—		—		—		—		—		—		—
Iehab Hawatmeh		—		6,000		—		0.01		01/03/28				—				—				—				—
Kathryn Hollinger		—		2,000		—		0.01		01/03/28				—				—				—				—

Director Compensation

Except for Iehab Hawatmeh, who is also our chief executive officer, we pay our directors $5,000 per year to serve on our board.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth certain information, as of April 1510, ~~2024~~2025, respecting the beneficial ownership of our outstanding common stock by: (i) any holder of more than 5%; (ii) each of the Named Executive Officers (defined as any person who was principal executive officer during the preceding fiscal year and each other highest compensated executive officers earning more than $100,000 during the last fiscal year) and directors; and (iii) our directors and Named Executive Officers as a group, based on 4,945,417 shares of common stock outstanding.

Name of Person or Group(1)	Nature of Ownership	Amount		Percent
Directors:
Iehab J. Hawatmeh	Common stock		211,554		4.3
	Options(2)		3024,000		*
			241,554		4.7
			235,554		4.7
Kathryn Hollinger	Common stock		26,003		*
	Options(3)		108,000		*
			36,003		*
All Executive Officers and Directors as a Group (2 persons):	Common stock		237,557		4.8
	Options(2)(3)		4032,000		*
	Total		~~277~~269,557		5.4

*	Less than one percent.
(1)	Address for all stockholders is 6360 S Pecos Road, Suite 8, Las Vegas, NV 89120.
(2)	Includes options to purchase shares that have been accrued for services provided during the preceding fiscal years and that have not expired. These options can be exercised any time at exercise prices ranging from $0.10 to $0.01 per share.
(3)	Includes options to purchase shares that have been accrued for services provided the preceding fiscal years and that have not expired. These options can be exercised any time at exercise prices ranging from $0.10 to $0.01 per share.

The persons named in the above table have sole voting and dispositive power respecting all shares beneficially owned, subject to community property laws where applicable. Beneficial ownership is determined according to the rules of the U.S. Securities and Exchange Commission, and generally means that a person has beneficial ownership of a security if he or she possesses sole or shared voting or investment power over that security. Each director, officer, or 5% or more stockholder has furnished the information respecting beneficial ownership.

Beneficial ownership is determined in accordance with the rules of the SEC, which generally attribute beneficial ownership of securities to persons who possess sole or shared voting power and/or investment power with respect to those securities. Unless otherwise indicated, voting and investment power are exercised solely by the person named above or shared with members of such person’s household. This includes any shares such person has the right to acquire within 60 days.

Changes in Control

There are no arrangements, known to us, including any pledge by any person of our securities, the operation of which may at a subsequent date result in a change in our control.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Information is set forth below for any transaction during the preceding fiscal year to which we were a party and in which any of our officers and directors or any holder of more than 10% of any class of our stock had or is deemed to have a material interest.

Related-Party Transactions

In 2007, we issued a 10% promissory note to a family member of our president in exchange for $300,000. The note was due on demand after May 2008. There were no repayments made during the periods presented. At December 31, ~~2023~~2024, the principal amount owing on the note was $151,833. No demand for payment has been made.

On March 31, 2008, we issued to this same family member, along with two other company shareholders, promissory notes totaling $315,000 ($105,000 each). These notes accrue interest at 12% per annum and are due on demand. We made no payments towards the outstanding notes during ~~2022.~~2023 and 2024. The principal balance owing on the notes as of December 31, ~~2023~~2024, of $72,466 is included in liabilities from discontinued operations.

As of December 31, ~~2023~~2024 and ~~2022~~2023, we owed our president a total of $433,379 and $433,379, respectively, in unsecured advances. The advances and short-term bridge loans were approved by our board of directors under a 5% borrowing fee. The borrowing fees were waived by our president on these loans. These amounts are included in our liabilities from discontinued operations.

As of December 31, ~~2023 and 2022~~2024, wethe ~~owed~~Company aowes ~~total~~the ofCEO $~~0 and $13~~7,~~740,~~059 ~~respectively,~~for toshort aterm ~~related~~advances ~~party~~to ~~through trade payables incurred in~~ the ~~normal course of business~~Company. ~~These~~The ~~amounts~~advances are ~~shown as a separate related~~non-~~party~~interest ~~payable~~bearing and due on ~~the balance sheet as of each reporting date~~demand.

During the ~~year~~years ended December 31, 2024 and 2023, we had a net decrease in deposits with a related-party inventory supplier totaling $223,774 and $193,222, respectively. The related party is an entity controlled by our chief executive officer. All transactions were at a 2% markup over the related-party’s cost paid for inventory in arm’s-length transactions. Total inventory purchases from the related party were $~~837~~1,~~618~~168,930 and $~~341~~837,~~734~~618 during the periods ended December 31, ~~2023~~2024 and ~~2022~~2023, respectively.

Director Independence

Under the definition of independent directors found in Nasdaq Rule 5605(a)(2), which is the definition we have chosen to apply, none of our directors is independent.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

The firm of Fruci & Associates has served as our independent registered public accounting firm since July 2020.

Audit Fees

For our fiscal year ended December 31, ~~2023~~2024, we were billed approximately $3237,~~600~~650 for professional services rendered for the audit and reviews of our consolidated financial statements. For our fiscal year ended December 31, ~~2022~~2023, we were billed approximately $3432,~~000~~600 for professional services rendered for the audit and reviews of our consolidated financial statements.

Audit Related Fees

For our fiscal years ended December 31, ~~2023~~2024 and ~~2022~~2023, we were billed approximately $~~11,250~~0 and $011,250, respectively, for audit-related fees.

Tax Fees

For our fiscal years ended December 31, ~~2023~~2024 and ~~2022~~2023, we were not billed for professional services rendered for tax compliance, tax advice, and tax planning.

All Other Fees

We did not incur any other fees related to services rendered by our principal accountant for the fiscal years ended December 31, ~~2023~~2024 and ~~2022~~2023.

Audit and Non-Audit Service Preapproval Policy

In accordance with the requirements of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder, our board of directors has adopted an informal approval policy that it believes will result in an effective and efficient procedure to preapprove services performed by the independent registered public accounting firm.

All professional services rendered by principal accountants for the audit of our annual financial statements that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for last two fiscal years were approved by our board of directors.

Audit Services

Audit services include the annual financial statement audit (including quarterly reviews) and other procedures required to be performed by the independent registered public accounting firm to be able to form an opinion on our consolidated financial statements. The board of directors preapproves specified annual audit services engagement terms and fees and other specified audit fees. All other audit services must be specifically preapproved by the board of directors. The board of directors monitors the audit services engagement and may approve, if necessary, any changes in terms, conditions, and fees resulting from changes in audit scope or other items.

Audit-Related Services

Audit-related services are assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements, which historically have been provided to us by the independent registered public accounting firm and are consistent with the Securities and Exchange Commission’s rules on auditor independence. The board of directors preapproves specified audit-related services within preapproved fee levels. All other audit-related services must be preapproved by the board of directors.

Tax Services

The board of directors preapproves specified tax services that it believes would not impair the independence of the independent registered public accounting firm and that are consistent with Securities and Exchange Commission’s rules and guidance. The board of directors must specifically approve all other tax services.

All Other Services

Other services are services provided by the independent registered public accounting firm that do not fall within the established audit, audit-related, and tax services categories. The board of directors preapproves specified other services that do not fall within any of the specified prohibited categories of services.

Procedures

All proposals for services to be provided by the independent registered public accounting firm, which must include a detailed description of the services to be rendered and the amount of corresponding fees, are submitted to the board of directors and the chief financial officer. The chief financial officer authorizes services that have been preapproved by the board of directors. The chief financial officer submits requests or applications to provide services that have not been preapproved by board of directors, which must include an affirmation by the chief financial officer and the independent registered public accounting firm that the request or application is consistent with the Securities and Exchange Commission’s rules on auditor independence, to board of directors for approval.

PART IV

ITEM 15. EXHIBITS and FINANCIAL STATEMENT SCHEDULES

Exhibit Number*	Title of Document	Location
Item 3.	Articles of Incorporation and Bylaws
3.01	Articles of Incorporation	Incorporated by reference from our Current Report on Form 8-K filed July 17, 2000
3.02	Amended and Restated Bylaws	Incorporated by reference from our Current Report on Form 8-K filed August 18, 2011
3.03	Articles of Amendment to Articles of Incorporation of CirTran Corporation	Incorporated by reference from our Current Report on Form 8-K filed August 18, 2011
3.04	Second Amendment to Articles of Incorporation of CirTran Corporation	Incorporated by reference from our Current Report on Form 8-K filed May 8, 2015
Item 4.	Instruments Defining the Rights of Security Holders, Including Debentures
4.01	Specimen stock certificate	Incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2019, filed May 29, 2020
4.02	Amended, Restated, and Consolidated Secured Convertible Debenture No. TK-1 in the amount of $3,437,798 payable to Tekfine, LLC	Incorporated by reference from the registration statement on Form 10 filed May 11, 2018
4.03	Secured Convertible Debenture No. TK-2 in the amount of $200,000 payable to Tekfine, LLC	Incorporated by reference from the registration statement on Form 10 filed May 11, 2018
4.04	Amendment No. 1 to Secured Convertible Debenture between CirTran Corporation and Tekfine, LLC, effective April 20, 2018	Incorporated by reference from the registration statement on Form 10 filed May 11, 2018
4.05	Amendment No. 2 to Secured Convertible Debenture between CirTran Corporation and Tekfine, LLC, effective May 12, 2020	Incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2019, filed May 29, 2020

2022

4.03	Secured Convertible Debenture No. TK-2 in the amount of $200,000 payable to Tekfine, LLC	Incorporated by reference from the registration statement on Form 10 filed May 11, 2018
4.04	Amendment No. 1 to Secured Convertible Debenture between CirTran Corporation and Tekfine, LLC, effective April 20, 2018	Incorporated by reference from the registration statement on Form 10 filed May 11, 2018
4.05	Amendment No. 2 to Secured Convertible Debenture between CirTran Corporation and Tekfine, LLC, effective May 12, 2020	Incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2019, filed May 29, 2020
Item 10.	Material Contracts
10.42**	Employment Agreement with Iehab Hawatmeh dated August 1, 2009	Incorporated by reference from our Annual Report on Form 10-K/A for the year ended December 31, 2011, filed April 30, 2012
10.49	CirTran Corporation 2013 Incentive Plan	Incorporated by reference from our Registration Statement on Form S-8 filed August 26, 2013
10.53**	Amendment No. 1 to Employment Agreement with Iehab J. Hawatmeh	Incorporated by reference from the registration statement on Form 10/A filed June 18, 2018
10.55	Exclusive Manufacturing and Distribution Agreement dated December 30, 2019	Incorporated by reference from our Current Report on Form 8-K filed January 27, 2020
10.56	Commercial Lease dated November 29, 2019	Incorporated by reference from our Current Report on Form 8-K filed January 27, 2020
Item 21.	Schedule of Subsidiaries
21.01	Schedule of Subsidiaries	Incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2019, filed May 29, 2020
Item 31.	Rule 13a-14(a)/15d-14(a) Certifications
31.01	Certification of Principal Executive and Principal Financial Officer Pursuant to Rule 13a-14	This filing
Item 32	Section 1350 Certifications
32.01	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	This filing
Item 101***	Interactive Data File
101.INS	Inline XBRL Instance Document	This filing
101.SCH	Inline XBRL Taxonomy Extension Schema	This filing
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase	This filing
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase	This filing
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase	This filing

Item 21.	Schedule of Subsidiaries
21.01	Schedule of Subsidiaries	Incorporated by reference from our Annual Report on Form 10-K for the year ended December 31, 2019, filed May 29, 2020
Item 31.	Rule 13a-14(a)/15d-14(a) Certifications
31.01	Certification of Principal Executive and Principal Financial Officer Pursuant to Rule 13a-14	This filing
Item 32	Section 1350 Certifications
32.01	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	This filing

Item 101***	Interactive Data File
101.INS	Inline XBRL Instance Document	This filing
101.SCH	Inline XBRL Taxonomy Extension Schema	This filing
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase	This filing
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase	This filing
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase	This filing

*	All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the document. Omitted numbers in the sequence refer to documents previously filed with the SEC as exhibits to previous filings, but no longer required.
**	Identifies each management contract or compensatory plan or arrangement required to be filed.
***	Users of this data are advised that, pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or Annual Report for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Exchange Act of 1934 and otherwise are not subject to liability.

ITEM 16. FORM 10-K SUMMARY

None.

2223

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CIRTRAN CORPORATION
Date: April 19, 2024	By:	/s/ Iehab Hawatmeh
Date: April 15, 2025	By:	/s/ Iehab Hawatmeh
		Iehab Hawatmeh, President
		Chief Financial Officer (Principal Executive
		Officer, Principal Financial Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Date: April 19, 2024	/s/ Iehab Hawatmeh
Date: April 15, 2025	/s/ Iehab Hawatmeh
	Iehab Hawatmeh, Director, President
	Chief Financial Officer (Principal Executive
	Officer, Principal Financial Officer)
Date: April 19, 2024	/s/ Kathryn Hollinger
Date: April 15, 2025	/s/ Kathryn Hollinger
	Kathryn Hollinger, Director

2324

Filing Compare · CIRTRAN CORP